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 Summary 
 
 
 
 
 
Current visions in cartilage repair aim at moving from fibrocartilaginous to a more 
hyaline like repair tissue by combining autologous cells of different origins (in situ 
recruited or in vitro precultivated) with repair supporting biomaterials. The role of a 
chondro-supportive biomaterial within a cartilage defect is seen to support 
infiltration/recruitment of chnodroprogenitor cells (CPC), accelerate their chondrogenic 
differentiation and to protect/modulate the newly formed tissue. 
 Overall, this thesis aimed at studying whether modification of selected substrate 
interface properties allows for modulating chondroprogenitor cell phenotype & function 
under expansion or differentiation conditions in vitro. The goal was to contribute to the 
definition of material characteristics which could be implemented in the design of 
biomaterials in order to improve current matrix assisted cartilage repair strategies and 
outcomes. 
 
Substrate composition & architecture (Chapter I) were found to modulate the 
chondrogenic differentiation of mesenchymal stem cells (MSC). Using a di block 
copolymer model substrate (Polyactive®) with a more hydrophobic composition better 
supported MSC chondrogenesis, than a more hydrophilic composition. Moreover, a 
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highly interconnected 3D fibre deposited scaffold architecture allowed for the formation 
of larger MSC aggregates and was found to considerably better support MSC 
chondrogenesis than compression molded scaffolds. 
 Restricting cell/substrate interaction specifically to an RGD-containing peptide 
ligand (Chapter II) modulated the de-differentiation of proliferating HAC and their 
subsequent capacity to form cartilaginous matrix. This demonstrated the advantage of 
small ECM fragments in combination with protein resistant materials to control 
cell/surface interaction. An important finding was the better maintenance of the HAC 
chondrocytic phenotype during expansion. It suggests, that an RGD-restricted substrate 
has the potential to improve the outcome of matrix assisted in situ cartilage repair, which 
initially requires recruited/infiltrated CPC to proliferate, while keeping/inducing their 
capacity to form cartilaginous matrix. 
 Substrate elasticity allowed for modulating the chondrogenic commitment of HAC 
(Chapter III). The finding, that a soft substrate (0.3kPa) better supported the chondrogenic 
phenotype of HAC than i.e. a stiffer substrate (75kPa) suggests this parameter to be 
promising for modulating the outcome of matrix assisted cartilage repair. 
 
Overall, this thesis demonstrates that substrate properties hold substantial potential to 
modulate CPC behaviour, which could be exploited to improve materials employed in 
matrix assisted cartilage repair. Yet, although differentially supporting CPC 
chondrogenesis, none of the substrates was per se chondro-inductive (see chapter I and 
III) but required for additional, exogenic stimuli as for e.g. transforming growth factor 
beta (TGF). Thus, modulatory substrate properties as i.e. architecture, composition, ligand 
presentation and stiffness should be combined with the instructive capacity of soluble 
stimuli to exploit the full potential of biomaterials in cartilage repair. 
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AA   Acrylamide; monomer 
ACI   Autologous chondrocyte implantation 
APS   Amonium persulfate 
BIS   N,N’-methylenbisacrylamide, crosslinker 
CM   Compression molded scaffold acrchitecture 
CPC   Chondroprogenitor Cells (i.e. MSC and expanded/de-diff. HAC) 
DMEM  Dulbecco’s modified Eagle’s medium 
DMSO  Dimethylsulfoxide 
DNA   Deoxyribonucleic acid 
dNTP   Deoxyribonucleosid triphosphates 
DTT   Dithiothreitol 
CDNA   Copy DNA 
CI   Type I Collagen 
CM   Complete medium 
E   Young’s modulus 
ECM   Extracellular Matrix 
EDTA   Ethylenediaminetetraacetic acid 
F-actin   Filamentous actin 
FBS   Fœtal bovine serum 
FG   Fibrin Glue 
FGF-2   Fibroblastic growth factor-2 
FN   Fibronectin 
GAG   Glycosaminoglycans 
G   Dynamic shear modulus 
G’   Shear storage modulus 
G’’   Shear loss modulus 
HAC   Human articular Chondrocytes 
HEPES  4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
MACI   Matrix assisted autologous chondrocyte implantation 
MRNA  Messenger RNA 
MSC   Mesenchymal stem cells 
NC   Nasal chondrocytes 
MW   Molecular weight 
N0   Initial number 
N1   Final number 
p   Perimeter 
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PA   Poly acrylamide 
PBS   Phosphate buffered saline 
PBT   Poly butylene terephtalate 
PCR   Polymerase chain reaction 
PDGF-BB  Platelet-derived growth factor 
PEG   Poly ethyleneglycol 
PEGT   Poly ethylene glycol terephtalate 
RGD   Peptide sequence Arg-Gly-Asp; cell adhesion motif in FN 
RNA   Ribonucleic acid 
rRNA   Ribosomal RNA 
SEM   Scanning electron microscopy 
SFM   Serum free medium 
Sox-9   Transcription factor Sox-9 
TCPS   Tissue culture treated plastic (gas plasma treated poly styrene) 
TGF   Transforming growth factor beta 
TGFβ-1  Transforming growth factor beta 1 
TGFβ-3  Transforming growth factor beta 3 
TMED   Tetramethylethylenediamine 
UV   Ultra violet light 350nm 
ν   Poisson ratio 
w%   Weight percent (g/g) 
w/   With 
w/o   Without 
φ Shape factor phi 
µCT   Micro computed tomography 
3DF   Three dimensional fibre deposited scaffold architecture 
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General Introduction 
 
 
 
Cartilage 
 
Major Types of Cartilage 
Cartilage is a specialized avascular connective tissue comprising of only one single type 
of cell called chondrocyte which is sparsely populated in a collagen and proteoglycan rich 
hydrated extracellular matrix (ECM). Based on the biochemical composition and structure 
of the ECM, the mechanical properties and structural characteristics of the tissue, three 
major types of cartilage (elastic cartilage, fibrous cartilage and hyaline cartilage) can be 
distinguished: 
 
i) Elastic cartilage is found in the pinna of the ear, in the walls of the auditory and 
eustachian canals and tubes, as well as in the larynx and in the epiglottis. This type of 
cartilage with a more elastic property maintains tube-like structures permanently open 
and provides intermediate mechanical stability. Elastic cartilage mostly consists of 
type II collagen matrix elements and elastic fiber bundles (elastin) which manifest in 
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aligned fiber structures. This structural composition provides a tissue which is stiff yet 
elastic. 
 
 
ii) Fibrocartilage is most prominently found in areas which require greater tensile 
strength and support such as i.e. between intervertebral discs and at sites of tendons or 
ligaments connected to bone tissue. Typically, fibrocartilage is found at locations 
which are under considerable mechanical stress (i.e. tendon and ligaments) but still 
provides properties which allow flexible body movement. Accordingly, fibrocartilage 
mainly consists of type I collagen fibers which are aligned in thick fiber bundles and 
chondrocytes arranged in parallel rows between these fibers. The fibrous type of 
cartilage is usually associated with a dense connective tissue, namely the hyaline type 
cartilage which defines the third type of cartilage (1) 
 
 
iii) Hyaline type cartilage is the most abundant type of cartilage and is found in 
the nose, Larynx, trachea, bronchi, in the ventral ends of the ribs, and at the articular 
ends of the long bones. Characterized by the arrangement of the chondrocytes in 
multicellular stacks which prominently produce a type II collagen and a proteoglycan 
rich matrix, the hyaline type of cartilage provides the flexible support in nose and ribs 
but can also sustain mechanical load during body motion as shown at the surface of 
articular joints. This hyaline type of cartilage is lining as a thin layer of deformable, 
load bearing tissue at the bony ends of diarthrodial joints and is more specifically 
called articular cartilage (1). 
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Composition and Structure of Articular Cartilage 
The primary function of articular cartilage is the absorption and distribution of forces, 
generated during joint loading and to provide a lubricating tissue surface which prevents 
the abrading and degradation of the joint and the subchondral bone structure during joint 
motion. Indeed, the articular type of hyaline cartilage has to bear and tolerate enormous 
physical stress and load during its entire lifetime. 
 
At first glance, articular cartilage may appear to be a relatively primitive tissue, which 
simply consists of chondrocytes entrapped in hydrated extracellular. However, in order to 
maintain its mechanical function and integration, this tissue reveals a unique, highly 
defined structural organization that can be subdivided into two domains, the i) cartilage 
zonation and ii) the organization of the extracellular matrix: 
 
i) The structure and composition of the entire articular cartilage tissue varies 
according to the distance from the tissue surface and reflects its functional role. 
Four different zones arranged as layers horizontally to the tissue surface can be 
distinguished and are characterized according to the extracellular matrix 
composition and cellular morphology (see Fig. 1). 
 
In the superficial zone the layer of tissue is composed of flattened ellipsoid-shaped 
chondrocytes and a high concentration of thin collagen fibers arranged in parallel 
to the articular surface (2). In this layer the pericellular matrix structure mentioned 
below can not be found. The thin layer of cells is covered with an acellular sheet 
of collagen fibers (lamina splendes) which functions as a protective barrier 
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between the synovial fluid and the cartilage tissue and controls the in- and egress 
of larger size molecules (3). Its rather low permeability regulates the diffusion 
transport of nutrients and oxygen to the underlying cartilage tructures. Only within 
this zone chondrocytes synthesize and secret the superficial zone protein lubricin 
(4;5) responsible to reduce surface friction during joint motion. The specific 
arrangement of the collagen fibrils which lay in parallel to the joint surface, 
provides a high mechanical stability of the tissue layer and mainly contributes to 
the tensile stiffness and strength of articular cartilage (6-9). 
 
Below the superficial zone is the midzone where cell density is lower. It displays 
more typical morphologic features of a hyaline cartilage with spherical/rounded 
cells and an extensive extracellular matrix rich in the proteoglycan aggrecan. The 
collagen fibers are synthesized at a lower quantity but show larger diameter fibrils 
which are aligned obliquely or randomly to the articular surface and describe an 
intermediate structure between the superficial zone and the adjacent deep zone. 
 
In the deep zone, the chondrocytes have a round morphology and are arranged in 
cell columns perpendicular to the cartilage surface. The extracellular matrix 
contains a high content of glycosaminoglycans and large diameter collagen fibers 
which form arcades perpendicular to the joint surface (10). 
 
The partially calcified zone defines the boundary of cartilage tissue to the 
subchondral bone. This rather thin layer of calcified cartilage with intermediate 
mechanical properties functions as a buffer between the cartilage and bone tissue. 
The cells have a smaller volume and are partially surrounded by calcified cartilage 
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matrix. The chondrocyte in this zone usually persist in a hypertrophic cell stage 
which correlates with the expression of collagen type X. Finally this boundary 
provides an optimal integration to the subchondral bone tissue and prevents 
vascular invasion. 
 
ii) In addition to the zonal segregation, the matrix surrounding the chondrocytes 
of articular cartilage varies in its organization and can be divided in three 
compartments, such as the pericellular region adjacent to the cell body, the 
territorial region enveloping the pericellular matrix, and the interterritorial 
compartment which defines the space between these cellular regions (see Fig. 1) 
(1). 
The pericellular region which is rich in proteoglycan, decorin, aggrecan, collagen 
type VI, and cell membrane associated molecules like anchorin and decorin (11-
13) defines a narrow rim of a filamentous matrix network which fulfills the 
functions of the interlink between the chondrocyte cell body and the territorial 
matrix structure. 
 
The territorial region describes an envelop surrounding the cells or cluster of cells 
with their pericellular matrix. Thin collagen fibrils (most prominently collagen 
type II) bind to the pericellular matrix and form a basket like structure which 
protects the cell from damage during loading and deformation of the cartilage 
tissue. Moreover these structures may also contribute to transmit mechanical 
signals to the chondrocytes during joint-loading (14;15). 
The interterritorial region confines the most volume of the articular cartilage 
tissue and contains intermolecular cross linked collagen fibrils (collagen type II), 
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non collagen proteins and aggregates of glycoproteins (16). This extracellular 
matrix composition provides the tissue with its functional characteristic to absorb 
mechanical load. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1 Schematic drawing of articular cartilage composition and structure. Articular cartilage can be divided into four 
different zones (superficial, mid, deep and calcified) which each has a characteristic composition and structure (inserts 
show organization and relative diameters of collagen macrofibrils in different zones). Reproduced from Poole et al. 
2001(17). 
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Mechanical environment in mature cartilage 
Chondrocytes and cartilage tissue during joint motion are exposed to body weight load 
which creates a rigorous mechanical environment for articular cartilage tissue such as 
direct compression, shear, and hydrostatic pressure. The function of articular cartilage to 
undergo tissue deformation is dependent on the specific arrangement of macromolecules 
in the extracellular matrix. Especially the organization of collagen fibers into a three 
dimensional arranged collagen network can balance the swelling pressure of the 
proteoglycan-water “gel” (18;19). Cartilage is considered as a viscoelastic material 
composed of three principal phases: a solid phase composed of a dense, collagen fibrillar 
network and charged proteoglycan aggregates, a fluid phase of water and an ion phase 
with ionic species for neutralizing the charged matrix components (20;21). Under 
physiological condition these three phases define an equilibrium where the extension of 
the proteoglycan-water gel volume is restricted by the firm collagen frame (22). The 
bound water in the cartilage tissue and finally the mechanical properties of the cartilage 
tissue are influenced by the interaction of water with the large, negatively charged 
proteoglycan aggregates (23). The negatively charged proteoglycans mostly driven by 
chondroitin sulphate residues are balanced by a high concentration of cations dissolved in 
the cartilage tissue (24). 
In summary, the mechanical function of articular cartilage tissue bases on the matrix 
structure surrounding each single cell, the arrangement of the extracellular matrix fibres 
within the single zonal compartment and the proportional composition of the different 
extracellular matrix components. 
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Cartilage Develompent 
Articular cartilage as a part of the limb skeleton develops in a well defined and controlled 
multistep differentiation process of cells from the mesenchymal origin (25-27). The 
establishment of the cartilage structure follows precise and distinct patterns of cell 
differentiation and cell rearrangement driven by environmental factors such as cell-cell 
and cell matrix interaction, growth factor and morphogen mediated signaling (28;29) as 
well as defined biomechanical conditions (30). 
The steps of development are divided into distinct phases (see Fig. 2). Initially phase 
mesenchymal precursor cells migrate from the lateral mesoderm towards the presumptive 
skeletogenic site and determine the cartilage anlagen (31). Following, the epithelial-
mesenchymal interactions results in the mesenchymal condensation. The pre-
chondrogenic condensation is a prerequisite for the future establishment of the limb 
skeleton (32) and is associated with an increased cell to cell contact which facilitate the 
intercellular communication and the transfer of small molecules between the cells (33). It 
has been shown that such a high cell density is required to allow chondrogenic 
development (34) and that the level of cell condensation correlates with the stage of 
chondrogenic development (35;36). Additionally, cell-matrix interactions appeared to 
play an important role in mesenchymal condensation (37). For example the integrin 
mediated binding of chondrocytes to collagen, has been shown to be essential for 
chondrocyte survival (38;39). Next, the overt differentiation of immature pre-
chondrocytes into fully committed chondrocytes is manifested by an increased cell 
proliferation and by the up-regulation of cartilage specific matrix components like 
collagen type IIα1, IX and XI and aggrecan. In the final commitment of the chondrogenic 
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phenotype the cells reduce their proliferative activity and maintain the functional integrity 
of the mature cartilage tissue (25-27). 
The initial function of the cartilage during embryonic development is to give stability to 
the embryo and serve as a template for myogenesis and later for neurogenesis. Most of 
the embryonic cartilage is replaced by bone during a process called the endochondral 
ossification (40;41). 
 
 
 
 
 
Fig. 2 Schematic representation of the multistep process of chondrogenesis in the developing limb bud. Undifferentiated 
mesenchymal cells derived from the lateral plate mesoderm aggregate to form condensations, which prefigure the future 
skeletal pattern. These cells differentiate into chondrocytes to undergo a series of differentiation processes including 
proliferation, hypertrophy and cell death. Proliferating chondrocytes are eventually arranged into parallel columns and 
subsequently exit the cell cycle to convert into hypertrophic chondrocytes. Following the onset of hypertrophy, 
chondrocytes direct mineralization and vascular invasion. On vascularization, osteoblasts are transported by blood 
vessels into the cartilage, producing bone matrix using the residual cartilage template as a scaffold. Concomitantly, 
hypertrophic chondrocytes undergo programmed cell death and are replaced by the bone matrix. Reproduced from 
Shimizu et al. 2007 (42). 
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During the endochondral ossification, the chondrocytes progress to the hypertrophic 
phenotype, which is characterized by a massive enlargement of the cell, the onset of the 
expression of type X collagen (43), an increased expression and activity of the alkaline 
phosphatase and the carbonic anhydrase and a reduction in the synthesis of the type II 
collagens and proteoglycan. Protease inhibitors which prevent vascular invasion are also 
reduced. Vascularization of the tissue takes place, and most or all of the hypertrophic 
chondrocytes undergo apoptosis followed by their replacement by osteoblasts which in 
turn will deposit bone matrix in the free lacunae. At the cell level, the entire endochondral 
ossification process can be seen as a sequential progression of the three chondrocytic 
phenotypes: the committed mesenchymal cell, the differentiated chondrocyte and the 
hypertrophic chondrocytes (44).  
Within these developmental processes growth promoting factors act on the cell and 
contribute to establish a mature cartilage tissue. 
 
 
Soluble Growth Factors Involved in Cartilage Development 
Within the multi step cell differentiation process a number of growth factors and 
morphogens are involved and essential during chondrocyte maturation and cartilage tissue 
formation. The most prominent growth factors belong to the transforming growth factor 
(TGF-β) superfamily which are responsible for chondrocyte proliferation (TGF-β1), 
terminal differentiation (TGF-β3; bone morphogenic protein; BMP) (45) or to promote 
cell-cell interaction in the early stage of chondrogenesis (BMP) (46). The insulin like 
growth factor 1 (IGF-1) which belongs to the IGF family of peptide hormones (including 
insulin) regulates many cellular functions during cartilage maturation such as induction of 
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chondrocyte differentiation (47) and proliferation (48). In mature cartilage IGF-1 
promotes and maintains the anabolic synthesis of proteoglycan and type II collagen (49) 
and inhibits the nitric oxide-induced de-differentiation of articular chondrocytes (50). 
Furthermore members of the fibroblast growth factor (FGF) family of morphogenes 
influence processes correlated with cell division and chondrocyte proliferation and have 
been shown to promote chondrocyte proliferation in a human growth plate ex vivo culture 
system (51). 
 
Finally, only the combinatorial action of these growth and morphogenic factors 
specifically expressed in selective tissue areas in different developmental phases and at 
defined concentrations establishes the precise structure of the articular cartilage tissue. 
 
 
 
 
Articular Cartilage Defects and Self Repair 
Articular cartilage lesions, caused by trauma, osteochondritis dissecans or as a result of 
instability or abnormal loading are a common cause of disability, often associated with 
pain, reduction of joint mobility and loss of function and can ultimately lead to 
osteoarthritis. Articular cartilage has a very limited intrinsic healing capacity, related to 
the absence of vascularization and the presence of few and very specialized cells with low 
mitotic activity. According to the size of cartilage tissue damage in the cartilage surface, 
several grades of tissue injury can be distinguished which lead to different healing 
response (52-54).  
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In the case of partial thickness defects, the classical self-repair of injured cartilage tissue 
goes through conserved mechanisms of cell and tissue necrosis followed by the 
proliferation of surviving chondrocytes adjacent to the site of the lesion. Although these 
cells aggregate in clusters and demonstrate a temporary increased type II collagen 
synthesis, in long term the formed tissue shows a lost of hyaline like cartilage 
characteristics. Thus, these chondral lesions remain almost unchanged and can proceed 
towards osteoarthritic diseases (55). 
 
In the case of full thickness defects, the lesion penetrates to the subchondral bone part 
gaining access to the cells that reside in the bone marrow space including the 
mesenchymal stem cells located therein. The repair response elicited by this type of 
defect results in the formation of a fibrocartilaginous tissue in the defect void. Anyhow, 
the decreased deposition of extracellular matrix components and the formed tissue with 
fibro-cartilage structures lack the strength, the mechanical properties and duration of the 
original articular cartilage tissue as it has been demonstrated in longer time follow-up 
studies (56;57). 
 
In comparison to native cartilage, the repair tissue generated by spontaneous self healing 
commonly shows limitations in regard to its composition and mechanical durability (see 
tab. 1) The discrepancy between native cartilage and repair tissue increases the 
probability of tissue and joint degeneration (58) and thus spurred the the development of 
articular cartilage defect treatments. 
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Table 1: Cellular, biochemical and mechanical characteristics of hyaline cartilage and fibrocartilage (59) 
 
 
 
Articular Cartilage Defect Treatments 
The different strategies to treat cartilage defects vary from more conservative approaches, 
like physiotherapeutic measures or application of pharmaceuticals (i.e. corticosteroids, 
hyaluoronic acid and growth factors) towards more invasive (i.e. surgical) procedures.  
 
Arthroscopic repair procedures 
Arthoscopic lavage and debridement are often used to alleviate joint pain. Lavage 
involves irrigation of the joint during arthroscopy, while debridement is the removal of 
the damaged tissue from the joint. Both of these procedures are routinely used to alleviate 
joint pain however do not induce repair of articular cartilage (60;61). 
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Osteochondral Transfer 
Osteochondral transplantation of autogenic and allogeneic tissue has been widely used to 
treat predominantly large osteochondral defects. Allogeneic material derived from 
cadaveric donors and it is indicated for large post traumatic defects of joints. Beaver et al. 
(62) reported satisfactory long-term results with these grafts, but the logistic of implanting 
a fresh allograft and the risk of transmitting infection reduce the indication for this 
procedure only to severe cases.Instead, autologous osteochondral graft implantation, 
involves the removal of cylindrical plugs of osteochondral tissue from non load bearing 
regions of the articular cartilage and their implantation into the prepared full depth defect 
with press-fit fixation. This procedure is indicated in osteochondral defects of 3 to 5 cm2 
in young patient. It provides the re-establishing of a functional cartilage surface which 
can-absorb body weight load but has limitation in terms of poor tissue integration within 
the adjacent native cartilage tissue. Furthermore, the surgical intervention damages intact 
host tissue and might enhance the donor site morbidity (63;64). 
Even though such invasive procedures hold promise and showed acceptable results in 
some cases the outcome of these procedures shows generally limitations in terms of 
quality and reproducibility (65). 
 
 
Cell Based Cartilage Repair Techniques 
Based on chondrocytes 
The first requirement of chondrocyte based cartilage repair techniques is the excision of a 
small biopsy of healthy cartilage from the patient for cell isolation and expansion. The use 
of growth factors allows a higher cell proliferation rate (66) which reduces culture time 
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required to obtain sufficient cell numbers. Tissue engineering of cartilaginous grafts is a 
challenging technique since dedifferentiation of chondrocytes, occurring during 
expansion (67-69), has to be reversed by culturing cells in substrates supporting a 
spherical morphology, such as polymer gels (70-72) or porous polymer scaffolds (73-75). 
The combination of all these steps clearly indicates that this technique is far from being 
an intraoperative procedure and is time and money consuming. 
 
Based on bone marrow stromal cells 
Bone marrow is a highly complex and organized tissue where several types of 
differentiated cells coexist with immature cells namely hematopoietic stem cells (HSC) 
which can self-renew and differentiate into all the mature peripheral blood types, and 
mesenchymal stem cells or marrow stromal cells (MSC) that serve as long-lasting 
precursors from bone marrow, bone, cartilage, and connective tissues (76-78)  
 
 
Ex vivo procedure 
Bone marrow mesenchymal stem cells (MSC) can easily be isolated by their adhesion to 
plastic, and grown in vitro. Monolayer expanded MSC have been shown to have the 
ability to differentiate in vitro into several mesenchymal tissue cells including 
chondrocytes, osteoblast, adipocytes and tenocytes when plated in appropriated 
environments (79). In particular, chondrogenesis of MSC occurs when these cells are 
cultured in three-dimensional aggregates (“pellets”) (80-82) or cultured on porous 
polymers in the presence of Transforming Growth Factor beta (TGFβ)(83).  
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MSC mobilized by microfracturing 
Defects of articular cartilage that penetrate the subchondral bone elicit an intrinsic 
fibrocartilaginous repair process. Mesenchymal stem cells from the bone marrow have 
been proposed to be involved in this regenerative process. Treatment of cartilage defect 
by microfracture (84) results in the formation of a fibrocartilaginous tissue which does not 
exhibit the same functional and mechanical properties that native hyaline cartilage (85). 
The main differences between hyaline and fibrocartilage are summarized in table 1. 
 
Recently, Kramer et al (86) showed that MSC from bone marrow migrate to a cartilage 
defect after microfracturing the subchondral bone and that these cells when guided in vivo 
to a collagen I/III membrane at the site of the defect were capable to differentiate in vitro 
into chondrogenic cell type under specific culture conditions. These findings show that 
while the treatment by microfracturing leads to fibrocartilaginous tissue formation, the 
cells originated from bone marrow have the capacity to generate cartilaginous tissue in 
vitro when placed cultured under appropriate conditions. 
In an attempt to enhance the filling of articular cartilage defect with functional repair 
tissue, collagen matrices have been used in conjunction with microfracture (procedure 
called autologous matrix-induced chondrogenesis, AMIC) in dog and sheep models (87-
89). After studying the in vitro chondrogenic differentiation of sheep MSC in a collagen 
matrix (90) Dorotka et al. (91) studied whether the implantation of such a matrix, 
supplemented or not with autologous chondrocytes would facilitate cartilage repair after 
microfracturing. However, the implantation of the collagen matrix did not enhance the 
quality of repair observed after microfracturing unlike the matrix which was cell seeded. 
In a canine model, Breinan et al. (92) investigated the effect of treating a cartilage defect 
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by microfracturing in combination with a type II collagen scaffold and demonstrated that 
after 15 weeks, implantation of the matrix increased the amount of tissue filling in the 
defect but the tissue was predomintantly fibrous in nature. 
 
These findings suggest that current materials lack chondroinductive and/or mechanical 
properties to properly stimulate the production of hyaline cartilage by the infiltrating 
progenitor cells. 
 
 
 
Chondro Progenitor Cells 
Both mesenchymal stem cells (MSC) and expanded/de-differentiated human articular 
chondrocytes (HAC) are known to undergo chondrogenic differentiation or re-
differentiation respectively, when cultured under chondrogenic conditions. From this 
perspective, both MSC and HAC can be considered as chondro progenitor cells. 
 
 
MSC 
Reservoirs of stem cells can be found throughout several tissues of the adult body 
and are thought to contribute to tissue regeneration upon trauma, disease or aging. 
Bone marrow i.e. contains mesenchymal stem cells, which can be isolated by 
adhesion to tissue culture plastic. When exposed to various growth factors, these 
adherent cells are capable of differentiating into connective tissue lineages 
including adipocytes, osteoblasts as well as chondrocytes (93). Chondrogenesis of 
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MSC can be induced by culturing them as aggregates in chemically defined 
medium containing insulin, dexamethasone, ascorbic acid and transforming 
growth factor beta (94). 
 
 
Expanded De-differentiated Chondrocytes 
During expansion in monolayer, human articular chondrocytes (HAC) are known 
to undergo rapid de-differentiatiation (95;96). De-differentiation of chondrocytes 
manifests by cell morphological transition from round to fibroblast-like, the loss 
of large proteoglycans (e.g. aggrecan) and type II collagen production (97;98), and 
the switch to synthesis of type I collagen, fibronectin (FN), and small 
noncartilaginous proteoglycans (98;99). 
The use of specific factors during monolayer expansion of HAC has been shown 
to accelerate the process of de-differentiation but induces HAC to acquire a 
differentiation plasticity which is similar to that of MSC (100). Culturing 
aggregates (suspension or pellet culture) of expanded/de-differentiated HAC in a 
medium containing the strong chondrogenic stimulus TGFβ-3, allows for re-
induction of chondrogenic differentiation (101;102). Thus, expanded/de-
differentiated HAC are not only of clinical relevance but, owing to their plasticity, 
also serve as a potent model to investigate processes involving fate commitment 
and the maintenance of mesenchymal progenitor cells. 
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Designed Biomaterials to Control Cell Function  
Generally, a biomaterial is any material, natural or synthetic, that comprises whole or part 
of a living structure or biomedical device which performs, augments, or replaces a natural 
function. Natural materials can provide a physical environment which influences cell 
function (103;104), but often suffer from high lot-to-lot variability, potential pathogens 
(105), and the risk to elicit an immune response upon implantation due to xenogenic 
protein components (106;107). In contrast to natural materials, synthetic materials offer 
the potential for improved control, repeatability, safety and scalability. Moreover, 
synthetic materials can be specifically designed on different length scales (molecular, 
cellular and macroscopic) and thereby allow to assemble targeted, physiological 
environments for controlling cell function (108). 
In recent years it has been recognized that biomaterials have to be tailored for each 
specific therapeutic application. Among the most important material properties to be 
controlled are: i) architecture, ii) ligand presentation as well as iii) mechanical properties 
(see Fig. 3) (108). 
 
 
i) Architecture 
The architectural organization of a biomaterial can be defined on different length 
scales ranging from nano- to millimetre. In the nano- to micrometer range, 
parameters like ligand presentation, cell-material interactions, force transmission, 
molecular diffusion and cell-cell interactions are governed (109-114). At larger 
scales, the material architecture determines bulk mechanical properties, possible 
cell seeding methods, cell migration and molecular diffusion (i.e. nutrient/waste 
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exchange) (115-118). Additionally, biomaterials can either be organized as two 
dimensional (2D) or three dimensional (3D) environments: 
 
o In traditional 2D culture systems, signalling and diffusion are inherently 
asymmetric. Still, such culturing platforms allow for simple observation of 
cell-material interaction, and can be straightforwardly produced 
(109;113;119). 
 
o For 3D scaffolds and regenerative implants, three predominant architectures 
have been used: porous solids, nanofibres and hydrogels. Microporous 3D 
solids with cell porosities greater than the cell diameter (115;117;118;120) 
may effectively signal as 2D surface (108). Nanofibrous scaffolds present a 3D 
nanostructured topology that resembles the fibrillar ECM proteins in vivo 
(121-123), whereas hydrogels simulate the hydrated structural aspect of native 
ECM (96;124-127). 
 
ii) Ligand Presentation 
Ligands modulate the cell phenotype in a manner dependent on their identity (i.e. 
specificity) (128-131) mode of presentation and density (132-135). Synthetic 
peptide ligands are often used in place of large proteins or protein fragments 
because of their stability and ease of synthesis, isolation, and conjugation to 
materials (136-141). 
The ligands must be conjugated to the material for proper presentation (e.g. 
surface immobilization, polymer modification, or creation of ligand macromers). 
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Peptide and protein ligands are typically conjugated to materials or material 
building blocks via primary amines (the amino terminus or lysines) or sulfhydryl 
groups (cysteines). In addition, spacer arm length and chemistry can in general be 
tuned to alter ligand availability and activity. Furthermore, the secondary and 
tertiary structures of native macromolecules frequently present ligands in a 
specific spatial conformation that promotes binding to receptors (142). 
 
 
iii) Mechanical Properties 
Apart from controlling ligand identity, density and presentation, which determine 
biomaterial/cell interaction(108), substrate mechanical properties have emerged as 
important, insoluble, mechanical cues. The mechanical properties of biomaterials 
are mainly determined by its composition, water content, and structure, which 
affect inter- and intramolecular forces as well as stress distribution. Common 
methods of altering the mechanical properties of biomaterials include modulating 
molecular composition and connectivity, thermal processing and creating 
reinforced porous composites (108). 
 
Adhesion ligands, which bind to integrins and other cell surface receptors, serve as 
mechanical transducers between the external material and the internal cytoskeleton 
of the cell, allowing cells to sense and respond to the stiffness of their 
substrates(108). Indeed, substrate mechanical properties have been shown to 
influence the phenotype of several members of the mesenchymal lineage, 
including fibroblasts(143;144), myoblasts(145;146) and osteoblasts(110). 
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Moreover mesenchymal stem cells (MSC) have been found to specify lineage and 
to commit to phenotypes with extreme sensitivity to tissue level elasticity. Soft 
substrates which mimic brain were neurogenic, stiffer substrates that mimic 
muscle were myogenic and comparatively stiffer substrates that mimic 
collagenous bone, proofed to be osteogenic (109). 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3 Design parameters for engineering synthetic stem cell materials. (a) Ligand identity, density, and presentation 
from the material surface dictate interactions with cell surface receptors to alter cytoskeletal linkages and intracellular 
signaling pathways. (b) Receptor–ligand interactions are further modulated by material architectures, which provide a 
two-dimensional (e.g. flat surfaces, microporous solids) or three-dimensional (e.g. nanofibers, hydrogels) micro-
environment for cellular engagement. (c) Also, the elastic and viscoelastic properties of the material determine the 
interplay between cell and material mechanics. Graphs schematically depict mechanical properties: elastic properties 
via a stress (s)–strain (e) plot and viscoelastic properties via a complex modulus (G*)–frequency (f) plot. Reproduced 
from Saha et al. (2007) Designing Synthetic materials to Control Stem Cell Phenotype (147). 
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Need for Characterizing Parameters for Chondro-Supportive Biomaterials 
Up to now there is no common agreement on what specific properties a substrate (i.e. a 
scaffold) should provide to autologous chondro progenitor (expanded/de-differentiated 
HAC or MSC) cells in order for them to form hyaline rather than fibrous cartilaginous 
matrix. Consequently, there is a clear need for defining biomaterial parameters from a 
biological perspective. Thus, this thesis is dedicated to studying the influence of specific 
tuneable controllable substrate characteristics 1) surface chemistry & architecture 2) cell 
adhesion ligand type 3) substrate stiffness on the potential of human chondro progenitor 
cells to exert their expected function. 
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Thesis Outline 
 
 
 
Clinical Relevance of Biomaterial Supported Cartilage Repair 
Since cartilage has a very limited capacity for self repair (148), standard treatments in 
attempt to overcome this limitation include the technique of microfracturing. This 
involves debridement of the damaged cartilage and drilling into the subchondral bone to 
allow for mesenchymal stem cells to invade and deposit cartilagineous matrix. However, 
the formed repair tissue is fibrous in nature, generally degrades after about half to one 
year post-surgery and thus the problems return for up to 90% of the patients (149;150). 
 
Current visions in cartilage repair aim at moving from fibrocartilaginous to a more 
hyaline like repair tissue by combining autologous cells of different origins (in situ 
recruited or in vitro precultivated) with repair supporting biomaterials (151). The role of a 
chondro-supportive biomaterial within a cartilage defect is seen to support 
infiltration/recruitment of chnodroprogenitor cells, accelerate their chondrogenic 
differentiation and to protect/modulate the newly formed tissue (152). 
 
Thus, the ultimate goal is to improve current clinical outcome from fibrous tissue towards 
hyaline-like cartilage by assisting cell based and micro fracturing stimulated repair with 
supportive biomaterials. 
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Fig. 1 Schematic view of cartilage repair/regeneration sequence following micro fracturing (adapted from a stepwise 
model system for limb regeneration by Endo et al. 2004 (153)). As indicated by the grey boxes (below the time axis), 
the repair process has been grouped into two main phases consisting of i ) proliferation and ii) differentiation from 
which in vitro conditions were inferred for testing the response of condroprogenitor cells (CPC) to specifically modified 
substrate interfaces. Boxes with dashed lines delimit the boundary of each chapter and indicate the type of substrate 
property addressed therein. Chapter I aimed at modulating CPC chondrogenic differentiation through modification of 
substrate composition & architecture. Chapter II aimed at modulating the phenotype of proliferating CPC by 
exclusively restricting their interaction with the substrate to an RGD containing peptide ligand. Chapter III aimed at 
modulating CPC behaviour during differentiation by modifying the substrate elasticity. 
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General Aim 
Overall, this thesis aimed at studying whether modification of selected substrate interface 
properties allows for modulating chondroprogenitor cell phenotype & function under 
expansion or differentiation conditions in vitro. The goal was to contribute to the 
definition of material characteristics which could be implemented in the design of 
biomaterials in order to improve current matrix assisted cartilage repair strategies and 
outcomes. 
 
 
Specific Aims and Models 
This thesis is divided into three chapters. Each chapter employed its own model substrates 
to modulate CPC (MSC or expanded/de-differentiated HAC respectively) behaviour and 
had its specific aims as described below (also see Fig. 1): 
 
• Chapter I  
Scaffold Composition & Architecture Modulates Chondrogenesis of Human 
Mesenchymal Stem Cells 
Aim: Test, whether chondrogenesis of expanded bone marrow derived 
mesenchymal stem cells (MSC) can be instructed/modulated by controlled 
modification of substrate composition and architecture. 
Model: Poly (ethylene glycol)-terephtalate-poly(buthylene)-terephtalate block 
copolymer scaffolds (PolyActive®) of two contrasting compositions (low or high 
poly (ethylene glycol) content: resulting in different wettablity) and two 
architectures generated by compression moulding (CM) or three dimensional fibre 
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deposition (3DF) with similar porosity and mechanical properties, but different 
interconnecting pore architectures were used. MSC seeded on the corresponding 
substrate were cultured under differentiation conditions +/- transforming growth 
factor beta 1 (TGF). 
 
 
• Chapter II 
An RGD-Restricted Substrate Interface Allows for Expansion and 
Subsequent Redifferentiation of Human Articular Chondrocytes 
Aim: Test, whether an RGD restricted substrate interface allows for human 
articular chondrocytes (HAC) growth, modulates their proliferation associated de-
differentiation and/or their post-expansion chondrogenic capacity. 
Model: HAC interaction with the substrate was restricted to RGD by modifying 
tissue culture treated polystyrene (TCPS) with a poly-(ethylene glycol) (PEG) 
based copolymer system that renders the surface resistant to protein adsorption 
while at the same time presenting the bioactive peptide ligand 
GCRGYGRGDSPG (RGD). In an in vitro comparison, HAC were cultured on 
RGD and the standard substrate TCPS under expansion conditions. The 
chondrogenic capacity of the expanded cells was subsequently tested in pellet 
culture under differentiation conditions. 
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• Chapter III 
Effect of Matrix Elasticity on the Re-differentiation Capacity of Expanded 
Human Articular Chondrocytes 
Aim: Test, whether substrate elasticity modulates the chondrogenic commitment 
of expanded human articular chondrocytes (HAC). 
Model: Providing an environment for differentiation, expanded/de-differentiated 
HAC were cultured on type I collagen functionalized poly acrylamide (PA) 
substrates of contrasting stiffness (0.3, 21 and 75kPa, tissue culture treated plastic 
(TCPS) as infinitely stiff control).  
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Chapter I 
 
 
 
SUBSTRATE COMPOSITION & 
ARCHITECTURE MODULATES 
CHONDROGENESIS OF HUMAN 
MESENCHYMAL STEM CELLS 
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INTRODUCTION 
Using two contrasting compositions of Poly (ethylene glycol)-terephtalate-
poly(buthylene)-terephtalate block copolymer scaffolds (PolyActive®; see Fig. 1), it was 
previously demonstrated that the re-differentiation capacity and cartilaginous matrix 
deposition of expanded human nasal chondrocytes (NC) could be modulated (117). In 
specific, the authors demonstrated that a hydrophilic (1000 PEG 70:30) as compared to a 
more hydrophobic (300 PEG 55:45) composition more strongly induced the chondro-re-
differentiation of NC (in absence of exogenous chondrostimuli, as i.e. TGFβ to the culture 
medium). This chondroinductive effect has mainly been attributed to an increase in the 
vitronectin/fibronectin adsorption ratio from serum by the more hydrophilic substrate 
(113). 
 
As in recent years human bone marrow derived mesenchymal stem cells (MSC) have 
been receiving increasing attention for regenerative medicine (152), we wanted to assess, 
whether the chondroinductive effect of the hydrophilic Polyactive® on NC also applies 
for expanded MSC. Thus, expanded MSC were cultured on PolyActive® scaffolds of 
different compositions under conditions published for NC (117). After four weeks of 
culture in DMEM complete medium, the MSC/scaffold constructs were histologically and 
biochemically analyzed for deposition of cartilaginous matrix. 
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Fig. 1 Composition and architecture of Polyactive® model substrate used throughout 
chapter one. Left panel shows a schematic drawing of the two different di block co-
polymers with a composition denoted as a/ b:c, where a represents the poly ethylene 
(PEG) molecular weight (g/mol) and b and c represent the weight percentage (wt%) of the 
poly (ethylene glycol) terephtalate (PEGT; hydrophilic) and the poly (butylene 
terepthalate) (PBT; hydrophobic) respectively. For simplicity, substrate composition 300 
PEG 55:45 (hydorphobic) and 1000 PEG 70:30 (hydrophilic) are denoted as 300 and 
1000 respecively. Right panels show three dimensional reconstructions of compression 
molded (CM) and 3D fiber deposited (3DF) architecture scaffolds from micro computed 
tomography (µCT) scans as adapted from (117). Scale bar represents 1mm. Compositions 
and architecture were selected based on previous work indicating their suitability for 
chondrocyte culture and cartilaginous matrix formation (117). 
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STUDY 1 
 
 
 
Aim 
It was investigated, whether chondrogenesis of expanded MSC can be 
instructed/modulated by controlled modifications of substrate composition and 
architecture. As a model system, poly(ethylene glycol)-terephtalate-poly(buthylene)-
terephtalate block copolymer substrates (PolyActive®) from two contrasting 
compositions (low or high PEG content, resulting in different wettablity) were used. From 
these two compositions, scaffold architectures of similar porosity, but different 
interconnecting pore architectures were employed. 
 - 38 - 
Methods 
 
Scaffold Fabrication 
PEGT/PBT copolymers were obtained from CellCoTec (Bilthoven, The Netherlands). 3D 
scaffolds made from 300 PEG 55:45 (300) and 1000 PEG 70:30 (1000) compositions 
(Fig. 1) were produced using either a compression molding (CM) and particle leaching 
technique (120) or a 3DF deposition technique (115;118). Briefly, CM scaffolds were 
prepared by mixing PEGT/PBT granules with sodium chloride grains (75% by volume), 
sieved to obtain particles ranging in size from 400 to 600 µm. After CM under heat and 
pressure, the polymerized PEGT/PBT block was then immersed in demineralized water 
for 48 h to remove the sodium chloride, and dried under reduced pressure in a vacuum 
oven. Porous 3DF scaffolds were constructed by successively layering a 0–901 pattern of 
molten PEGT/PBT fibers from a ∅250µm nozzle onto a computer controlled x2y2z table. 
Fibers within each layer were spaced 1.0mm apart, but were offset (staggered) by 0.5mm 
between layers to optimize the ‘‘visible’’ surface available for cell seeding. Square blocks 
of 30x30x4mm3 were produced with a consistent pore size, 100% interconnecting pore 
volume and a porosity of 56%. Cylindrical scaffolds, 2-3mm in height, 4.7mm diameter, 
were cored from the bulk of porous CM and 3DF blocks prior to cell seeding. Previous 
thermal analysis studies have demonstrated that CM and 3DF processing techniques do 
not result in changes of PEG MW or PEGT/PBT composition (118). Therefore, any 
differences seen in this study between architectures of CM and 3DF scaffolds should not 
be related to differences in scaffold composition. Due to enhanced instruction of 
chondrogenesis in de-differentiated chondrocytes on the 1000 chemistry (117), the 
variation of architecture (CM/3DF) was restricted to this composition. 
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Cell Isolation and Expansion 
Bone marrow derived mesenchymal stem cells (MSC) were obtained as described 
previously (154). In brief, one bone marrow aspirate was obtained during a routine 
orthopaedic surgical procedure involving exposure of the iliac crest, after informed 
consent. A marrow aspirate (20 ml volumes) was harvested from a healthy donor (female, 
34 years) using a bone marrow biopsy needle inserted through the cortical bone; the 
aspirate was immediately transferred into a plastic tube containing 15,000 IU heparin. 
 
Bone marrow nucleated cells were counted after staining with Crystal Violet 0.01% in 
phosphate-buffered saline (PBS, both from Sigma-Aldrich, Switzerland) and plated at a 
density of 1x105 cells/cm2 in alpha minimal essential medium containing 4.5 mg/ml D-
glucose, 0.1 mM non-essential amino acids, 1 mM sodium pyruvate, 10 mM HEPES 
buffer, 100 U/ml penicillin, 100 µg/ml streptomycin, and 0.29 mg/ml L-glutamine, 
supplemented with 10% FBS (all from Gibco, UK; αMEM complete ) supplemented with 
5 ng/ml fibroblast growth factor-2 (R&D Systems, Wiesbaden, D) to enhance 
proliferation and enrich the pluripotent MSC population (155). MSC were cultured in a 
humidified 37°C/5% CO2 incubator with medium changes twice a week. MSC were 
selected on the basis of adhesion and proliferation on the plastic substrate. Upon reaching 
subconfluency, MSC were detached using 0.05% trypsin/0.53 mM EDTA (GIBCO-BRL, 
CH) and replated at a density of 3’000 cells/cm2 (passage 1, p1). Reaching confluency 
(p2), MSC were detached and seeded onto scaffolds as described below. 
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Cell Seeding and Culture on Three Dimensional Scaffolds 
Cylindrical scaffolds were prewetted with 70% ethanol, thoroughly rinsed with 
autoclaved milliQ water, soaked in Dulbecco’s modified Eagle’s medium (DMEM) 
containing 4.5 mg/ml D-glucose, 0.1 mM non-essential amino acids, 1 mM sodium 
pyruvate, 10 mM HEPES buffer, 100 U/ml penicillin, 100 µg/ml streptomycin, and 0.29 
mg/ml L-glutamine, 10% FBS (all from Gibco, UK; DEMEM complete) and blotted dry 
on a sterile paper. Expanded MSC (p2; 2.5 Mio./scaffold) were allowed to clott in DMEM 
complete CM for 20 min. prior to statically seeding them onto scaffolds placed in dishes 
coated with a thin film of 1% agarose. Seeding volume/scaffold was adjusted to 30µl for 
the CM 300, 50µl for the CM 1000 and 37µl for the 1000 3DF to compensate for the 
differential swelling inherent to the corresponding combination of composition and 
architecture. Constructs were placed in dishes coated with a thin film of 1% agarose and 
statically cultured in 2ml DMEM complete supplemented with 10 mg/ml insulin and 
0.1mM ascorbic acid, either without or with 10ng/ml TGFβ-3 (TGF), with medium 
changes twice a week. TGF is a strong chondrostimulus (94;156) and was included in the 
culture medium as a contingency measure, in case the scaffold per se would not be 
chondro- instructive/inductive for MSC. After four weeks of culture, constructs were 
harvested and processed for gene expression as well as for histological and biochemical 
analysis. 
 
Biochemical Analysis 
Constructs cultured for four weeks were digested with protease K (0.5 ml of 1 mg/ml 
protease K in 50 mM Tris with 1 mM EDTA, 1 mM iodoacetamide, and 10 µg/ml 
pepstatin-A) for 15 hours at 56°C (157). The glycosaminoglycan (GAG) content was 
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measured spectrophotometrically using dimethylmethylene blue (158), with chondroitin 
sulfate as a standard, and normalized to the DNA amount, measured 
spectrofluorometrically using the CyQUANT Kit (Molecular Probes, Eugene, OR), with 
calf thymus DNA as a standard. GAG contents are reported as µg GAG / µg DNA. 
 
Cell Seeding Efficiency and Retention 
The number of cells was estimated by measuring the amount of DNA in protease K 
digested constructs (as described in biochemical analysis). Cell seeding efficiency was 
determined 24 hours after seeding (initial) and expressed as percentage of seeded cells 
(aliquots of 2.5 Mio. MSC from the cell suspension used for seeding onto the scaffolds 
corresponding to 100%). Cell retention was estimated by measuring the amount of DNA 
present in the constructs at the end of four weeks of culture and comparing it to the initial 
amount of DNA.  
 
Histological and Immunohistochemical Analysis 
Constructs cultured for four weeks were fixed in 4% formalin for 24 h, embedded in 
paraffin, cross-sectioned (12 µm thick), and stained with Safranin O for sulphated GAG 
(100). Sections were also processed for immunohistochemistry to visualize type II 
collagen (II-II6B3, Hybridoma Bank, University of Iowa, USA), as previously described 
(159). 
Structural integrity of the scaffold was better maintained on the 300 compared to the 1000 
composition. For the latter, sections could be retrieved only where tissue formation had 
occurred. Otherwise, only small fractures of the constructs could be captured (Fig. 2C). 
For the 3DF 1000 (Fig. 2E&F), the scaffold material was completely lost, leaving behind 
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white holes. Scaffold loss was an inevitable artefact introduced during the mounting of 
histological sections (low adhesion and swelling inherent to the 1000 composition). 
Gene Expression Analysis 
RNA was extracted from tissue constructs using 250 µl Trizol (Life Technologies, Basel, 
CH) according to the manufacturer’s instructions. Extracted RNA was treated with 
DNAse following the instructions of the Rneasy Kit (Ambion, Austin TX). cDNA was 
generated from total RNA using reverse-transcriptase Stratascript (Stratagene) in the 
presence of dNTP and DTT. Real-time PCR reactions were performed and monitored 
using the ABI prism 7700 Sequence Detection System and the Sequence Detector V 
program (Perkin-Elmer Applied Biosystems). cDNA samples were analyzed for type I & 
II collagen and for the housekeeping gene (18S ribosomal RNA), using previously 
described sequences of primers and probes (100). Each cDNA sample was assessed in 
duplicate and the collagen mRNA expression levels were normalized to the corresponding 
18S rRNA levels. 
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Results 
One day after seeding expanded MSC onto the scaffolds, the constructs with CM 
architecture revealed a higher seeding efficiency on the 300 (74±2%) compared to the 
1000 (62±2%) composition as determined by the amount of DNA. For the 1000 
composition, a change in scaffold geometry from CM to 3DF enhanced the seeding 
efficiency (72±3%). The presence of TGF did not change the seeding efficiency (<7±5% 
vs. (-) TGF) and the fraction of cells released to the medium was always below 17±3%. 
After four weeks of static culture, the retention of MSC on the PolyActive® scaffolds was 
estimated by measuring the amount of DNA present in the constructs (Fig. 3A). 
Generally, the CM scaffolds maintained their initial DNA level throughout the four weeks 
of culture, and there was even a slight increase (11±9%) in DNA on the 300 composition. 
On the 3DF architecture in contrast, the final DNA level nearly dropped to half (57±5%) 
of the initial level. Overall, MSC retention on PolyActive® did not seem to be affected by 
the presence of TGF in the culture medium. 
 
Constructs cultured for 4 weeks were formalin fixed, paraffin embedded and stained for 
glycosaminoglycans (GAG) with safranin O (Fig. 2). Despite for the CM 1000 where 
little to no tissue could be retrieved, MSC were able to deposit matrix in all conditions. In 
absence of TGF (Fig. 2A, C, E) formed tissue was predominantly fibrotic, showed no 
GAG deposition and even became necrotic in parts (Fig. 2E, upper left corner of inset 
detail view). In presence of TGF, GAG deposition was faintly more visible on the 300 
(Fig. 3B) than on the 1000 (Fig. 3D) composition with CM architecture. Strongest GAG 
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Fig. 2 Light microscopy images of safranin O stained (red: glycosaminoglycans, GAG), representative histological 
cross-sections of MSC cultured on PolyActive® for four weeks without (A, C, E) or with (B, D, F) chondrogenic 
stimulus TGF. Small insets show higher power magnifications of large sections shown in corresponding large panel. In 
F, the upper insert shows a type II collagen stained section consequtive to that stained with safranin O (directely below). 
Polyactive® composition were 300 PEG 55:45 (300; A&B) and 1000 PEG 70:30 (1000; C-F) in either compression 
molded (CM; A-D) or 3D fiber deposited (3DF; E&F) architecture. Structural integrity of the scaffold was better 
maintained for the 300 (brown structures) compared to the 1000 (violet structures) composition. For the latter, sections 
could be retrieved only where tissue formation had occurred as i.e.for C, only small fractures of the constructs could be 
captured. In E&F the scaffold material was completely lost, leaving behind white holes. Scaffold loss was an inevitable 
artifact introduced during the mounting of histological sections (low adhesion and swelling inherent to the 1000 
composition). Despite strong focal GAG staining on the 3DF 1000 (F), deposited tissue in A-E was mostly fibrotic, 
showed little to no GAG accumulation and in E (upper left corner on inset) even displayed necrotic portions. Scale bars: 
400 µm (large panels), 100 µm (insets). 
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staining and presence of rounded cells was detected on the 3DF 1000 in presence of TGF 
(Fig. 2F). Only for this condition, collagen type II could be detected by 
immunohistochemistry (Fig. 2F upper inset). 
Quantitative, biochemical analysis of accumulated GAG (Fig. 3B) matched with the 
histological findings. The marginal amounts of GAG/DNA deposited in the absence of 
TGF were increased by 2 to 4-fold in presence of TGF, reaching the highest value on 
3DF1000. 
 
Fig. 3 MSC retention and glycosaminoglycan (GAG) accumulation after 4 weeks of culture on Polyactive® scaffolds 
without or with chondrogenic stimulus TGF. Panel A displays the initial amount of DNA (white bars) and that found 
after four weeks (black bars) of culture. Despite the marginal increase in DNA on the 300 PEG 55:45 (300) 
composition, the compression moulded (CM) scaffolds in general maintained their initial DNA level throughout the 
culture period. On the 3D fiber deposited (3DF) scaffolds in contrast, initial DNA levels were almost halfed (57±5%). 
The presence of of TGF did not change this pattern. Panel B shows the amount of accumulated GAG (normalized vs. 
Amount of DNA at the end of culture) as determined biochemically. The addition of TGF raised the basal levels of 
GAG/DNA by 2 to 4-fold. The highest GAG/DNA value was reached by the 3DF 1000 while comparing the CM 
architecture only, the 300 tended towards higher GAG/DNA than the 1000 composition. Error bars represent the 
standard deviation.Comparing the CM architecture only, the 300 tended towards higher values than the 1000 
composition. 
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Expression levels of mRNA (Fig. 4) revealed more drastic differences than revealed by 
the accumulation of cartilaginous matrix but followed the same trends/patterns. Type I 
collagen mRNA (indicator of fibrocartilage) expression was always expressed more 
strongly than type II collagen (indicator of hyaline cartilage). Most drastic were the 
mRNA expression changes introduced by adding TGF, which in average raised type I 
collagen ~300-fold and type II collagen by several orders of magnitude (4.5E+6). In 
presence of TGF, highest type II collagen mRNA expression was found on the 3DF 1000 
which was four orders of magnitude higher than that found on CM of the same chemistry. 
Comparing the CM architecture only, type II collagen mRNA was more than 40 times 
higher on the 300 than it was on the 1000. 
 
 
Fig. 4 Type I & II collagen mRNA expression of MSC cultured for four weeks on Polyactive® scaffolds without or 
with TGF. Genes of interest (G.o.I) were normalized vs. housekeeping gene (HK) 18S. Panel A: type I collagen, panel 
B: type II collagen. Error bars indicate standard deviation. 
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Discussion 
Using two contrasting compositions and architectures, scaffolds made of PolyActive® 
were per se not able to induce chondrogenesis in MSC. However, in presence of exogenic 
chondrogenic stimulus TGF, chondrogenesis could be observed which tended to be better 
supported by the more hydrophobic 300 composition and was further enhanced by 
changing the scaffold architecture from CM to 3DF. These findings indicate, that 
controlling scaffold composition and architecture is important to support, but per se not 
sufficient to instruct/induce chondrogenesis in MSC. 
 
Marginal proliferation in any of the conditions excludes the possibility that 
chondrogenesis was indirectly regulated through differential cell proliferation. Although 
initially cell seeding efficiency was comparable in all the conditions, a marked loss of 
cells from 3DF 1000 scaffolds over four weeks of culture reveals a low affinity of MSC 
for this combination of composition and architecture and prompts for very careful liquid 
handling during medium changes. Since histological sections indicate that this cell loss 
did not lead to an obvious decrease in local cell density (1000 compostition; 3DF vs. CM) 
this unlikely affected chondrogenesis of the retained/remaining MSC.  
In contrast to the findings with nasal chondrocytes (117), non of the PolyActive® 
compositions and architecture compositions per se allowed for chondrogenesis in MSC. 
However, supplementing the culture medium with TGF stimulated chondrogenesis in 
MSC and revealed this process to be slightly modulated by scaffold composition and 
more strongly by its architecture. Although selectively adsorbed serum proteins (113;160) 
on the scaffold surface has been reported to instruct human chondrocyte re-differentiation 
(117), this stimulus alone does not seem to suffice for instructing chondrogenic 
 - 48 - 
differentiation in less committed cells as i.e. MSC. In this light, it appears more 
appropriate to consider the applied scaffold materials chondro-supportive, instead of 
chondro-instructive. Also, further investigations on the influence of PolyActive® 
compostition and architecture on MSC differentiation should be perfomed in presence of 
a chondrogenic stimulus. A common approach to induce chondrogenesis in MSC, is 
supplementing the culture medium with a strong differentiation stimulus as i.e. TGFβ 
(94;156). As an alternative to, exogenous soluble differentiation stimuli, MSC could be 
exposed to paracrine signals present in an osteochondral microenvironment (161). To this 
end, a recently introduced ectopic in vivo mouse model for human cartilage repair could 
offer an experimental solution (162). Therein, a MSC/scaffold construct could be placed 
in a defined osteochondral defect (disk from human femour head explants) and cultured 
subcutaneously in a nude mouse. 
 
In presence of TGF, chondrogenesis of MSC always followed the same trend which was 
3DF 1000 > CM 300 > CM 1000. Thus both, scaffold composition and architecture 
appeared to modulate MSC chondro-differentiation. That the 300 composition better 
supported chondrogenesis, contradicts previous reports for nasal chondrocytes (NC) 
which showed superior chondrogenic differentiation on the 1000 (117). Yet, despite the 
plasticity of expanded NC (unpublished results), MSC are presumably more progenitor-
like. Thus, they could be more sensitive to passing through developmental checkpoints as 
i.e. cellular condensation to enter chondrogenic differentiation. Therefore, MSC could 
profit from higher fibronectin (FN) concentration present on the 300 than on the 1000, 
since FN plays a crucial role in aggregation of cells into mesenchymal condensations 
(163). In the developing limb bud, cellular condensation is a key step for chondrogenesis 
of mesenchymal cells as it allows for the appropriate microenvironment through 
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homotypic cell-cell interactions (for review see (164)). In contrast to MSC, to de-
differentiated chondrocytes (as i.e. NC), which already have already passed through 
condensation once, FN likely provides a different stimulus as i.e. spreading (117), which 
is known to interfere with re-differentiation (165). While this explanation is quite 
speculative, there is no doubt that that NC (neuro ectoderm) and MSC (mesoderm) are of 
quite different germ layer origin and thus likely react to the same stimulus in a different 
manner. 
The higher degree of chondrogenic differentiation mediated by the 3DF architecture 
(comparing 1000 composition only) is in line with findings for human nasal chondrocytes 
(117). Lower structural complexity and bigger average pore size of the 3DF facilitate 
diffusion rate of nutrients and gases as well as waste removal and likely contribute to this 
effect (116). Moreover, the low affinity of MSC for the 1000 composition combined with 
the low structural complexity of the 3DF architecture (i.e. high interconnectivity of the 
pores) could facilitate MSC condensation into larger aggregates. 
 
Outlook 
Due to its superior performance, follow-up investigations of substrate chemistry influence 
on MSC chondrogenesis could be restricted to the 3DF architecture. However, this should 
be preceded by an optimization of the cell culture protocol in order to prevent cell loss. 
Under optimized in vitro conditions, the effect of substrate chemistry should be 
reassessed with MSC from another donor, to test the robustness of the observed effect. 
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STUDY 2 
 
 
 
 
 
 
 
Aim 
It was investigated, whether chondrogenesis of expanded MSC can be 
instructed/modulated by controlled modifications of scaffold composition under 
optimized in vitro conditions. As a model system, poly(ethylene glycol)-terephtalate-
poly(buthylene)-terephtalate block copolymer scaffolds (PolyActive®) with 3D fiber 
deposited (3DF) architecture of two contrasting compositions (low or high PEG content, 
resulting in different wettability) were used. 
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Methods 
Scaffold Fabrication 
See study 1. Compared to the compression molded (CM), the 3D fibre deposited (3DF) 
scaffolds better supported chondrogenesis of MSC. Thus, in this study scaffold 
architecture was focussed on 3DF. 
 
MSC Isolation and Expansion 
For this study, a bone marrow aspirate (20 ml volume) from a healthy donor (male, 44 
years) was used. MSC were isolated and expanded as described in study 1. 
 
Optimization of in vitro Culture Conditions 
Based on the findings of the previous study, the in vitro culture conditions were optimized 
for this study. In particular, i) medium composition and ii) cell retention were optimized 
as follows: 
 
i) The composition of chondrogenic differentiation medium which was adapted 
from that previously used for nasal chondrocytes, resulted in limited 
chondrogenesis of MSC (see study 1). Since foetal bovine serum suppressed 
TGFβ-1 induced chondrogenesis in synoviocytes pellet culture (166) a serum free 
medium chondrogenic medium (102) was tested as an alternative to the previously 
used serum containing medium (DMEM complete; see study 1). The 
chondrogenesis of MSC in presence or absence of serum was investigated in  
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Fig. 5 Light microscopy images of Safranin O stained (red: glycosaminoglycans, GAG), representative histological 
pellet cross-sections. To test whether chondrogenesis of MSC could be improved using a serum free medium, MSC 
were cultured as pellets in either (A) 10% serum containing DMEM complete medium as applied for study 1, or (B) 
serum free medium (SFM), or to isolate the effect of serum in (C) SFM supplemented with 10% serum. To stimulate 
chondrogenesis, all media contained 0.1 mM ascorbic acid, 10 mg/ml insulin and 10 ng/ml transforming growth factor 
beta 1 (TGF). MSC aggregated with fibrin glue (D) were also cultured in SFM chondrogenic medium. This was done to 
isolate the effect of fibrin glue on the chondrogenesis of MSC as it was included in this study to improve MSC retention 
on the 3D fiber deposited scaffolds. Scale bars: 100µm (large panels), 400µm (small panels). 
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pellet cultue (see Fig. 5A&B). In brief, aliquots of 5x105 MSC/0.5ml were 
centrifuged at 250 g for 5 min. in 1.5 ml polypropylene conical tubes (Saarstedt, 
Nümbrecht, Germany) to form spherical pellets. These pellets were cultured either 
in serum containing DMEM complete (see previous study), or in a chemically 
defined, serum-free medium (SFM), which consists of DMEM containing 4.5 
mg/ml D-glucose, 0.1 mM non-essential amino acids, 1 mM sodium pyruvate, 10 
mM HEPES buffer, 100 U/ml penicillin, 100 µg/ml streptomycin, and 0.29 mg/ml 
L-glutamine (all Gibco, UK). To isolate the effect of serum, SFM was 
supplemented with 10% FBS. Additionally, all media were supplemented with the 
chondrogenic factors ITS+1 (10 µg/ml insulin, 5.5 mg/ml transferrin, 5 ng/ml 
selenium, 0.5 mg/ml bovine serum albumin, 4.7 mg/ml linoleic acid), 1.25 mg/ml 
human serum albumin, 0.1 mM ascorbic acid 2-phosphate and 10-7 M 
dexamethasone (all Sigma Chemical, USA) and 10 ng/ml TGF-β1 (R&D, UK). 
Pellets were cultured for 4 weeks at 37°C / 5% CO2, with medium changes twice 
per week.  
Light microscopy images of safranin O stained representative histological pellet 
sections revealed that not only the SFM medium improved the chondrogenesis in 
MSC but also that serum had a negative effect thereon and even led to necrosis 
(see Fig. 5C).  
 
ii) As on the 3DF scaffold with the 1000 composition almost half of the initially 
seeded MSC were lost throughout the culture period, low concentration fibrin glue 
(FG; TISSEEL® kit, Baxter, Vienna, Austria, dilution 1:16) was used to improve 
cell retention. Fibrin glue consists of a fibrinogen aprotinin solution (contains 
Factor XIII), which coagulates when combined with thrombin and calcium 
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chloride. Taking advantage of FG mediated coagulation, homogenous cell 
distribution and quantitative seeding efficiency was achieved on 1000 3DF 
scaffolds (data not shown). To test whether FG interferes with chondrogenesis, FG 
entrapped MSC were cultured in chondrogenic differentiation medium (see Fig. 
5D). For this, aliquots of 5x105 MSC/0.5ml were centrifuged at 250 g for 5 min. in 
1.5 ml polypropylene conical tubes (Saarstedt, Nümbrecht, Germany). The pellet 
was resuspended with 52 µl of 7 mg/ml fibrinogen solution (contains aprotinin as 
a protease inhibiting FG stabilizer) and the cell suspension transferred to a conicial 
polypropylene tube containing 10 µl of 31 U/ml thrombin in solution (in 40 mM 
CaCl2) where the mixture was allowed to clot. FG entrapped MSC cultured in 
SFM supplemented with chondrogenic factors (as described above) for four weeks 
of culture (Fig. 5D) were comparable to conventional pellets (see Fig. 5B) in their 
accumulation of GAG. As FG was not found to interfere with MSC 
chondrogenesis, FG was applied in this study to optimize MSC retention on the 
3DF scaffolds as described below. 
 
 
Chondrocyte Seeding and Culture on Three Dimensional Scaffolds 
Cylindrical scaffolds were prewetted with 70% ethanol and thoroughly rinsed with 
autoclaved milliQ water. Prewetted scaffolds were soaked in DMEM complete for 1 hour. 
This allowed for differential adsorption of serum proteins on the two contrasting 
compositions, and has been described to be responsible for their difference in modulating 
chondocyte redifferentiation (113). Subsequently, the scaffolds were blotted dry on a 
sterile paper, loaded with a corresponding volume (300: 25 µl; 1000: 55 µl) of 31 U/ml 
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thrombin in 40 mM CaCl2 solution and placed in an agarose coated 12 well plate for 5 
min. before blotting dry again. Holding the scaffold with forceps, P2 expanded MSC (2.5 
Mio/scaffold) in the corresponding volume (300: 25 µl; 1000: 55 µl) of 7 mg/ml 
fibrinogen (in the supplied aprotinin solution) were seeded onto the scaffolds. Seeding 
volume/scaffold was adjusted to compensate for the differential swelling inherent to the 
corresponding composition. The cell loaded construct was placed on top of 10 µl 31 U/ml 
thrombin solution (in 40 mM CaCl2) in an agarose coated 12 well plate and allowed to 
stand for 2 min. prior to adding the corresponding medium. Constructs were statically 
cultured in 2ml of either DMEM complete or SFM supplemented with 10 mg/ml insulin, 
0.1mM ascorbic acid and 10ng/ml TGFβ-3 (TGF) for 4 weeks, with culture medium 
changes twice a week. After harvesting, constructs were processed for histological and, 
biochemical or gene expression analysis. 
 
Biochemical analysis, cell seeding efficiency & retention, histological & 
immunohistochemical analysis: see study 1. 
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Results 
One day after seeding expanded MSC onto the scaffolds using fibrin glue (FG), seeding 
was found to be quantitative and comparable on both scaffold chemistries. With 96±10% 
for the 300 and 104±11% for the 1000 composition, the seeding efficiency was more than 
20% higher than that achieved previously without FG on 3DF 1000 (see study 1). 
After four weeks of static culture, the retention of MSC on the PolyActive® scaffolds was 
estimated by measuring the amount of DNA present in the constructs (Fig. 7A). There 
was a slight loss of DNA on the 300 composition which tended to be stronger in presence 
of serum (DMEM complete; 19±10%) than in serum free medium (SFM; 11±5%). On the 
1000 in contrast, the final amounts of DNA were increased and tended to be higher in the 
absence of serum (27±13%) than in DMEM complete (8±4%). 
 
Constructs cultured for 4 weeks were formalin fixed, paraffin embedded and stained for 
glycosaminoglycans (GAG) with safranin O (Fig. 6). In all conditions, MSC were able to 
deposit matrix, which in presence of serum was predominantly fibrotic and showed no 
GAG deposition (Fig. 6A&C). All constructs were encapsulated by several layers of cells 
with flattened morphology. This capsule was denser/thicker where serum was present and 
thinnest for the 300 composition in absence of serum. Some core regions seem to have 
become necrotic as they contain a dense aggregation of nuclei (Fig. 6 lower left panels in 
A & B; blue dots). In absence of serum, GAG staining was faint on the 1000, clearly 
stronger on the 300 and for both compositions most intense just beneath the construct 
periphery. On the 300, the staining additionally reached into the core regions of the 
construct. 
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Fig. 6 Light microscopy images of Safranin O stained (red: glycosaminoglycans, GAG), representative histological 
cross-sections. MSC cultured on PolyActive® for four weeks in either serum containing (DMEM complete: A, C) or 
serum free (SFMCh: B, D) medium supplemented with chondrogenic factors including 10 ng/ml TGF. Polyactive® 
architecture was 3D fiber deposited (3DF) with a composition of 300 PEG 55:45 (300; A&B) and 1000 PEG 70:30 
(1000; C, D). Small panels (left: core region, right: periphery) show higher power magnifications of corresponding 
overview panel. Structural integrity of the scaffold (round, brown structures) was better maintained for the 300 
compared to the 1000 composition. Scaffold loss was an inevitable artefact introduced during the mounting of 
histological sections (low adhesion and swelling inherent to the 1000 composition). Fibrin glue improved tissue 
integrity and allowed for preparing entire histological cross-sections. In all conditions, MSC were able to deposit 
matrix, which in presence of serum was predominantly fibrotic and showed no GAG deposition (A&C). All constructs 
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were encapsulated by several layers of cells with flattened morphology. This capsule was denser/thicker where serum 
was present and thinnest for the 300 composition in absence of serum. Some core regions seem to have become necrotic 
as they contain a dense aggregation of nuclei (lower left panels in A & B; blue dots). In absence of serum, GAG 
staining was faint on the 1000, clearly stronger on the 300 and for both compositions most intense just beneath the 
construct periphery. On the 300, the staining additionally reached into the core regions of the construct. Scale bars: 800 
µm (large panels), 200 µm (small panels). 
 
Quantitative, biochemical analysis of accumulated GAG (Fig. 7) matched with the 
histological findings. In presence of serum, GAG deposition remained marginal and was  
only slightly higher on the 300 (28%) than on the 1000 composition. Compared to 
DMEM complete, SFM allowed for increased GAG accumulation (300: 2.5x; 1000: 1.4x) 
and was 2.3x higher on the 300 than on the 1000 composition. Constructs with the 300 
compositon reached approximately 70% of the GAG/DNA level found in pellet controls 
(data not shown). 
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Fig. 7 MSC retention and glycosaminoglycan (GAG) accumulation over 4 weeks of culture on Polyactive® scaffolds in 
presence of (DMEM complete) or without serum (SFM). Panel A displays the initial amount of DNA (white bars). 
Measurements were only done for constructs in SFM, as they are not thought to be affected by medium composition in 
short term (24 hours). Black bars show the amount of DNA found after four weeks of culture. All conditions maintained 
their initial DNA levels or even permitted for an moderate increase (<27%) throughout the culture period. The average 
increase was higher in SFM than in presence of serum. Panel B shows the amount of accumulated GAG (normalized vs. 
the mount of DNA at the end of culture) as determined biochemically. In presence of serum, GAG deposition remained 
marginal and was only slightly higher on the 300 (28%) than on the 1000 composition. In contrast to DMEM complete 
however, SFM allowed for increased GAG accumulation (300: 2.5x; 1000: 1.4x) which was 2.3x higher on the 300 than 
on the 1000 composition. Error bars represent the standard deviation. 
 
 
 
Discussion 
Using two contrastingly different compositions, scaffolds made of PolyActive® did not 
support chondrogenesis in MSC if serum was present in the chondrogenic medium. In 
absence of serum however, chondrogenesis could be observed and tended to be better 
supported by the more hydrophobic 300 composition. This finding indicates, that 
controlling scaffold composition can be employed to support chondrogenesis in MSC, but 
strongly depends on additional soluble instructive/inductive stimuli like i.e. TGF. 
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For both substrate compositions, fibrin glue modified seeding allowed for quantitative 
seeding efficiency and cell retention, while changing to a serum free chondrogenic 
medium allowed for improved MSC chondrogenesis. 
An adverse effect of serum on MSC chondrogenesis was evident in both pellets (Fig. 5C) 
as well as in constructs (Fig. 6). This observation is in line with previous findings in 
which serum has been found to suppress TGF induced chondrogenesis in synoviocyte 
pellet culture (166). Although, constructs were cultured in serum free medium, prior to 
cell seeding substrates were soaked in serum containing medium. This should have 
allowed for composition inherent, differential serum protein adsorption which has 
formerly been argued to be the key to the differential support of chondrogenic 
differentiation on Polyactive® substrates of contrasting chemical compostition (113). 
Fibrin glue (FG) could potentially mask this proteinaceous interface amd thus was applied 
at a diluted concentration. However, under comparable culture conditions as applied in 
this study, chondrocytes were capable to degrade even higher concentrated FG after two 
to three days (167). Similar behaviour may be expected from MSC due to their ability to 
secrete fibrinolytic enzymes which facilitate the degradation of fibrin clots (168). Thus, 
altough FG may have delayed MSC/substrate-interface interaction it unlikely has been 
able to ultimately mask it. This view also finds support by the fact that although FG was 
present in this study, the trends for the substrate composition observed in study 1 could be 
reproduced. 
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CONCLUSION STUDY I & II 
Taken together, in both studys substrate composition & architecture was found to 
modulate the chondrogenic differentiation of MSC. That the di block copolymer model 
substrate (Polyactive®) with a more hydrophobic composition better supported MSC 
chondrogenesis, is likely associated with differential protein adsorption (from serum 
containing medium). However such proteinaceous interfaces are rather complex with 
regard to protein composition and conformation thereon. This conceals the specific cues 
responsible for mediating the observed effects and thus strongly prompts for reducing the 
substrate interface complexity in subsequent investigations of chondroprogenitor cell-
substrate interactions. 
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Chapter II 
 
 
 
RGD-PEPTIDE RESTRICTED 
INTERACTIONS WITH A  
PROTEIN RESISTANT 
SUBSTRATE ARE SUFFICIENT 
FOR HUMAN ARTICULAR 
CHONDROCYTE ADHESION, 
GROWTH & MAINTENANCE OF 
CARTILAGE  
FORMING CAPACITY 
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ABSTRACT 
 
 
 
This study aimed at testing whether an RGD-restricted substrate interface is sufficient for 
adhesion and growth of human articular chondrocytes (HAC), and whether it enhances 
their post expansion chondrogenic capacity. HAC/substrate interaction was restricted to 
RGD by modifying tissue culture treated polystyrene (TCPS) with a poly-(ethylene 
glycol) (PEG) based copolymer system that renders the surface resistant to protein 
adsorption while at the same time presenting the bioactive RGD-containing peptide 
GCRGYGRGDSPG (RGD). As compared to TCPS, HAC cultured on RGD spread faster, 
better maintained their chondrogenic phenotype and had a lower spreading area. 
Attachment and proliferation, as well as type II collagen mRNA expression in the 
subsequent chondrogenic differentiation phase, were similar to those of HAC cultured on 
TCPS. In contrast, cartilaginous matrix deposition by HAC expanded on RGD was 
slightly but consistently higher. RDG (bioinactive peptide) and PEG (no peptide ligand) 
controls yielded drastically reduced attachment and proliferation, thus indicating 
specificity of RGD. The restriction of cell-substrate interactions to RGD could be 
implemented in materials for cartilage repair, whereby in situ recruited/infiltrated 
chondroprogenitor cells would proliferate while maintaining their ability to differentiate 
and generate new cartilage tissue. 
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INTRODUCTION 
Human articular chondrocytes (HAC) have received great attention in the context of cell-
based repair of cartilage, which per se has a very limited regeneration capacity (148). One 
of the current therapies to overcome this limitation is to restore the damage by autologous 
chondrocyte implantation (ACI) (169). In this procedure, HAC are enzymatically 
extracted from a small articular cartilage biopsy and subsequently expanded in vitro to 
obtain a sufficient number of cells for implantation. During expansion, HAC de-
differentiate and their redifferentiation capacity is often limited (95;96). De-
differentiation of chondrocytes manifests by cell morphological transition from round to 
fibroblast-like, the loss of large proteoglycans (e.g. aggrecan) and type II collagen 
production (97;98), and the switch to synthesis of type I collagen, fibronectin (FN), and 
small noncartilaginous proteoglycans (98;99). This raises the problem, that subsequent to 
monolayer culture the de-differentiated chondrocytes have the propensity to produce 
fibrocartilaginous tissue which is of inferior mechanical quality as compared to hyaline 
cartilage. 
Tissue culture treated polystyrene (TCPS; gas plasma activated polystyrene) currently is 
the gold standard substrate for HAC monolayer expansion. It readily adsorbs proteins that 
are present in serum containing culture medium, which rapidly leads to the formation of a 
proteinaceous adlayer, determining the subsequent cell-surface interaction (170). The 
nature of such interfaces is highly complex with regard to composition and conformation 
of the adsorbed proteins (171). Since the biology of chondrocytes is highly influenced by 
interactions with specific extracellular matrix (ECM) molecules (172;173), controlled 
modification of cell culture substrates with biological motives has the potential to 
improve HAC expansion strategies. 
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A typical approach to investigate substrate effects on chondrocyte phenotype has been to 
coat TCPS with specific ECM-protein solutions. As compared to on plastic substrates, 
chicken epiphysial chondrocytes longer retained their native morphology on type II 
collagen coatings (129), and rabbit articular chondrocytes better preserved their 
phenotype on type I collagen (128). In contrast, however, other studies showed that the 
expression of type I and II collagen by chondrocytes was not altered in response to 
substrates coated with either type I or II collagen or fibronectin (174;175). The 
controversial results could at least partially be due to the fact that simple application of 
natural protein layers lacks control over the presentation of active ligands to the cells 
(176). In fact, protein adsorption is generally governed by electrostatic interactions, van 
der Waals forces and short range repulsion forces and occurs randomly in various 
different orientations of the protein (177). Also, it has been demonstrated on a variety of 
surfaces including TCPS, that adsorption can induce conformational changes in several 
different proteins as for example in collagen and results in alteration of the native protein 
biological activity (for review see (178)). The uncertainties introduced by working with 
natural protein layers has driven the development and synthesis of materials which 
provide full control over the ligand-receptor interactions (179), not only for optimizing 
cell culture labware but also for the development of smart materials in regenerative 
medicine. 
The peptide sequence RGD is present in several ECM-proteins like fibronectin, collagens 
and vitronectin and not only serves as the minimal requirement for integrin-mediated cell 
anchoring (180), but also provides signals which can modulate chondrocyte morphology, 
motility, proliferation and differentiation. Mice with a cartilage specific deletion of beta 1 
integrins have abnormally shaped chondrocytes, that fail to arrange into columns within 
the growth plate and show a decreased proliferation rate (181). In the developing mouse 
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zegopod, it was even shown, that blocking α5β1 integrin interaction with RGD from the 
ECM inhibits pre-hypertrophic chondrocyte differentiation and eventually leads to 
apoptosis (182). Although a great variety of materials has been modified with RGD, their 
in vitro biological effect has largely been tested on animal cell lines and often restricted to 
cell attachment, morphology and proliferation, mostly leaving unadressed the impact on 
the cell phenotype and on the cell differentiation capacity (for review see (141)). No study 
has yet assessed primary human articular chondrocyte expansion on a fully controlled, 
RGD-restricted substrate. 
In this work, we tested whether an RGD-restricted substrate interface is sufficient to 
allow for HAC adhesion, growth and maintenance of the chondrogenic capacity. In 
particular, HAC attachment, spreading kinetics, morphology, proliferation, gene 
expression and post-expansion cartilage formation were assessed on a poly-(ethylene 
glycol) (PEG) based copolymer system that renders the surface resistant to protein 
adsorption while at the same time presenting the bioactive, RGD-containing peptide 
GCRGYGRGDSPG (RGD) (183-185). HAC culture on RGD was compared to that on 
tissue culture treated polystyrene (TCPS, standard substrate) and on control PEG 
substrates, without or with the scrambled sequence RDG. 
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METHODS 
 
Fig. 1: Schematic view of the experimental design. Subsequent to isolation from three different donors (age 53-
66years), human articular chondrocytes (HAC) were expanded either on RGD-functionalized PLL-g-PEG (RGD) or the 
standard substrate, tissue culture treated polystyrene (TCPS). The scrambled sequence RDG-functionalized PLL-g-PEG 
(RDG) and PLLg-PEG served as negative controls. Subsequent to expansion, HAC were re-differentiated in pellet 
culture in presence of serum free chondrogenic medium. 
 
 
Polymer Synthesis and Characterization 
Peptide-functionalized and non-functionalized PLL-g-PEG polymers were synthesized 
and characterized as previously published (139;186) . In brief, these polymers are based 
on a PLL backbone of approximately 120 L-lysine units (average value in view of the 
polydispersity of 1.4 of the polymer; Sigma-Aldrich, Buchs, CH), a PEG side chain of 
approximately 47 ethylene glycol units (PEG MW 2 kDa, polydispersity: 1.02; Nektar, 
Bradford, UK) and a grafting ratio (g) between 3.3 and 4.6, expressed as the number of 
lysine monomers per PEG side chain. A vinyl sulfone-modified PEG chain of 3.4 kDa 
molecular weight (polydispersity: 1.01; Nektar, Bradford, UK) was used to couple the 
peptide sequences with the PLL backbone. The following peptides were used for the 
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synthesis of functionalized PLL-g-PEG polymers: the bioactive RGD-containing N-
acetyl-GCRGYGRGDSPG-amide and the scrambled (bio-inactive) N-acetyl-
GCRGYGRDGSPG-amide (both purchased from Jerini, Berlin, GER). Polymer 
architectures (grafting ratios and fractions of peptide-functionalization) were determined 
with nuclear magnetic resonance spectroscopy (NMR) whereas adsorbed polymer and 
serum masses were measured using optical waveguide lightmode spectroscopy (OWLS) 
(see Table 1 for details). All polymers used were proven to be highly resistant to non-
specific serum adsorption (<5 ng/cm2). 
 
 
Tab 1. Molecular weight, grafting ratio, peptide functionalization, polymer/protein adsorption and peptide surface 
density for all polymers used in this paper. aMeasured with NMR technique, bmeasured with OWLS technique. cSee 
Schuler, et al. 2006 (186) for details. 
 
 PEG RGD RDG 
Molecular weight PLL [kDa] 15.9 15.9 15.9 
Molecular weight lysine unit [kDa] 0.128 0.128 0.128 
Molecular weight peptide [kDa] - 1.222 1.222 
Molecular weight entire polymer [kDa] 91.1 52.8 56.8 
Grafting ratio g [-]a 3.3 7.0 6.4 
Peptide-functionalized PEG-chains [%]a - 3.4 3.7 
Polymer adsorption [ng/cm2]b 150 143 135 
Protein adsorption [ng/cm2]b < 5 < 5 < 5 
Peptide surface density ρps [pmol/cm2]c - 1.6 1.7 
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Surface Modification for Cell Culture 
For modifying the surface of tissue culture treated polystyrene (TCPS; atmospheric gas 
plasma treated polystyrene), frozen samples of dehydrated PLL-g-PEG polymer powders 
were warmed up to room temperature, dissolved in a salt buffer solution (denoted 
hereafter as HEPES2) containing 10 mM HEPES and 150 mM NaCl at pH 7.4 (to reach a 
final concentration of 0.5 mg/ml) and filter sterilized (0.22 µm filter, Milian, Basel, CH). 
TCPS dishes/flasks (TPP, Tarasdingen, Switzerland) and Thermanox® lamellae (Nunc, 
USA, for CLSM, activated with a UVO-Cleaner (Model 42-220, Jetlight Company, 
USA)) were coated at room temperature for 45 min. with 100 µl/cm2 of the above 
described polymer solutions while stirring on an orbital shaker. Supernatant polymer 
solution was aspirated and surfaces were washed twice with 200 µl/cm2 HEPES2 buffer 
solution for 5 min. For convenience, PEGylated surfaces will be named hereafter 
according to their peptide sequences (PLL-g-PEG/PEG-RGD as RGD and PLL-g-
PEG/PEG-RDG as RDG) whereas the non-functionalized PLL-g-PEG surface will be 
denoted as PEG. 
 
Cell isolation and Expansion 
Full thickness human articular cartilage samples were collected within 24 hours post 
mortem from the femoral lateral condyle of three different donors (age in years; A:53, 
B:62, C:66), with no history of joint disease, after obtained informed consent, following 
protocol approval by the local ethical commitee (No. 78/07) (Fig. 1, HAC Isolation). 
HAC were isolated upon 22-hour incubation at 37 °C in 0.15% type II collagenase and 
resuspended with Dulbecco’s modified Eagle’s medium (DMEM) containing 4.5 mg/ml 
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D-glucose, 0.1 mM non-essential amino acids, 1 mM sodium pyruvate, 10 mM HEPES 
buffer, 100 U/ml penicillin, 100 µg/ml streptomycin, and 0.29 mg/ml L-glutamine, 
supplemented with 10% FBS (all from Gibco, UK) (DMEM complete). For the first 
expansion phase, HAC from each donor were seeded onto either TCPS, RGD, RDG or 
PEG substrates at a concentration of 104 cells/cm2. HAC were cultured in CM 
supplemented with 1 ng/ml TGF-ß1, 5 ng/ml FGF-2, 10 ng/ml PDGF-BB (expansion 
medium, all from R&D, UK) in a humified 37°C/5% CO2 incubator. These specific 
growth factors have previously been shown to enhance HAC proliferation and post-
expansion redifferentiation capacity (Fig. 1, HAC Expansion) (102). HAC were detached 
at confluency (passage 1) by a treatment with 0.3% type II collagenase, followed by 
0.05% trypsin/0.52 mM EDTA (Gibco, UK), re-plated on the corresponding surfaces at a 
density of 5 x103 cells/cm2 for the second expansion step, and cultured in expansion 
medium until they reached confluency again (passage 2). 
 
Cell Attachment & Proliferation 
To determine cell attachment 24 hours after inoculation (Fig. 1, HAC Expansion), 
supernatants containing non-adherent cells were collected, counted in a Neumann 
chamber and their viability was assessed using Trypan blue (Sigma Chemical, USA). The 
non-adherent HAC from RDG and PEG were returned to the corresponding dishes at each 
medium change. Cell proliferation rate was calculated as the ratio of log2 (N/N0) to T, 
where N0 and N are the numbers of cells respectively at the beginning and the end of the 
expansion phase, and T is the time required for the expansion (102). 
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Cell Morphology 
HAC after the second confluency on TCPS or RGD were detached, reseeded onto a 
correspondingly coated lamellae at a density of 5 x103 cells/cm2 and cultured in 
expansion medium in a humified 37°C/5% CO2 incubator for three days. The lamellae 
were then rinsed with PBS (Gibco, UK). Rinsed HAC were fixed with 1% glutaraldehyde 
in PBS for 30 min. at room temperature. Substrates were rinsed with PBS before 
permeabilizing and further fixing with 2 % Octyl-polyethylene (Octyl-POE) and 0.125% 
glutaraldehyde for 5 min. Following a PBS wash, residual glutaraldehyde was reduced 
with a solution of 0.5 g/ml NaBH4 in PBS at 0°C for 20 min. After washing with PBS 
again, HAC were labeled with TRITC-phalloidin 1:900 (λEx=488 nm, Sigma Chemicals, 
USA) against actin filaments and DRAQ5 1:200 (λEx=647 nm, Alexis Biochemicals) to 
label DNA in the nuclei (all dilutions in PBS). Finally, the lamella were mounted onto a 
glass slide using mowiol-1188 (Hoechst, Frankfurt, Germany) containing 0.75 % of the 
anti-fading agent N-propyl-gallate (Sigma Chemicals, USA) and stored at 4°C in the dark. 
Fluorescence images were acquired with a Leica TCS SP CLSM, using a 63x HC PL 
APO immersion objective. The number of stacks was fixed to 20, while each stack 
(1024x1024 pixel2) was scanned at medium speed and averaged four times. 
To describe the HAC morphology and the degree of spreading, a cell shape factor φ (Eq. 
1) was used (186;187).  
 
        (1) 
 
The area A and the perimeter p required for calculating the shape factor φ were 
determined from the CLSM images using Image J version 1.37 (188). A shape factor for a 
round cell can assume values near to one. Circles have the greatest area-to perimeter ratio 
2p
Aπ4
=φ
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and their shape factor φ is 1, whereas a thin, thread-like object would have a shape factor 
φ.near 0. 
 
Initial Cell Spreading, Kinetic & Motility 
Time lapse microscopy experiments were performed on an Olympus IX81 motorized, 
inverted microscope in phase contrast mode, using a 10x LCPFL objective combined with 
a 1.6x magnifying lens (to investigate initial spreading) or an UplanApo 4x objective (to 
investigate motility). The microscopes were equipped with a high resolution position 
controller to drive the motorized stage. HAC were seeded onto either TCPS or RGD in 
expansion medium at a density of 104 cells/cm2 (for studies on initial spreading) or 
7.5x103 cells/cm2 (for studies on motility) and kept in a box at 37°C / 5% CO2. The initial 
spreading kinetic of HAC was followed for 18 min. Starting 5 min. post seeding, every 
two min. an image was acquired from 15 randomly selected areas of each substrate. Using 
Image J, the spreading kinetic of 28 cells, which were at the onset of spreading, was 
determined on each surface based on the spreading area. 
 
 
Chondrogenic Assay 
The chondrogenic capacity of HAC expanded on either TCPS or RGD was investigated in 
pellet culture (Fig. 1, HAC Redifferentiation) using a chemically defined, serum-free 
medium (SFM), which consists of DMEM containing 4.5 mg/ml D-glucose, 0.1 mM non-
essential amino acids, 1 mM sodium pyruvate, 10 mM HEPES buffer, 100 U/ml 
penicillin, 100 µg/ml streptomycin, and 0.29 mg/ml L-glutamine (all Gibco, UK) 
supplemented with ITS+1 (10 µg/ml insulin, 5.5 mg/ml transferrin, 5 ng/ml selenium, 0.5 
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mg/ml bovine serum albumin, 4.7 mg/ml linoleic acid), 1.25 mg/ml human serum 
albumin, 0.1 mM ascorbic acid 2-phosphate and 10-7 M dexamethasone (all Sigma 
Chemical, USA) and 10 ng/ml TGF-β1 (R&D, UK) (chondrogenic medium) (100;189). 
Aliquots of 5x105 HAC/0.5ml were centrifuged at 250 g for 5 min. in 1.5 ml 
polypropylene conical tubes (Saarstedt, Nümbrecht, Germany) to form spherical pellets, 
which were placed onto a 3D orbital shaker (Bioblock Scientific, Frenkenkdorf, 
Switzerland) at 30 rpm. Pellets were cultured for 2 weeks at 37°C / 5% CO2, with 
medium changes twice per week, and subsequently processed for histological, immuno-
histochemical, biochemical and mRNA analysis. 
 
 
Gene Expression Analysis 
RNA was extracted from tissue constructs using 250 µl Trizol (Life Technologies, Basel, 
CH) according to the manufacturer’s instructions. Extracted RNA was treated with 
DNAse following the instructions of the Rneasy Kit (Ambion, Austin TX). cDNA was 
generated from total RNA using reverse-transcriptase Stratascript (Stratagene) in the 
presence of dNTP and DTT. Real-time PCR reactions were performed and monitored 
using the ABI prism 7700 Sequence Detection System and the Sequence Detector V 
program (Perkin-Elmer Applied Biosystems). cDNA samples were analyzed for type I, II, 
X collagen and for the housekeeping gene (18S ribosomal RNA), using previously 
described sequences of primers and probes (100). Each cDNA sample was assessed in 
duplicate and the collagen mRNA expression levels were normalized to the corresponding 
18S rRNA levels. 
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Biochemical Analysis 
HAC pellets cultured in chondrogenic medium for two weeks were digested with protease 
K (0.5 ml of 1 mg/ml protease K in 50 mM Tris with 1 mM EDTA, 1 mM iodoacetamide, 
and 10 µg/ml pepstatin-A) for 15 hours at 56°C (157). The GAG content was measured 
spectrophotometrically using dimethylmethylene blue (158), with chondroitin sulfate as a 
standard, and normalized to the DNA amount, measured spectrofluorometrically using the 
CyQUANT Kit (Molecular Probes, Eugene, OR), with calf thymus DNA as a standard. 
GAG contents are reported as µg GAG / µg DNA. 
 
Histological and Immunohistochemical Analysis 
Cell pellets cultured in chondrogenic medium were fixed in 4% formalin for 24 h, 
embedded in paraffin, cross-sectioned (5 µm thick), and stained with Safranin O for 
sulphated glycosaminoglycan (GAG) (100). Sections were also processed for 
immunohistochemistry to visualize type II collagen (II-II6B3, Hybridoma Bank, 
University of Iowa, USA), as previously described (159). 
 
Statistical Analysis 
Statistical evaluation was performed using SPSS software (version 15.0, SPSS Schweiz 
AG, Zürich, Schweiz). All mean values are presented as standard error (±SE). Differences 
between the surfaces TCPS, RGD and PEG were assessed using complying statistical 
tests as indicated at each result. The level of significance was set to p < 0.05. 
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RESULTS 
 
 
Substrate Characterization 
The RGD modified surface was determined to have a PLL-g-PEG/PEG-RGD–polymer 
concentration of 143 ng/cm2 (see Table 1). This concentration was sufficient to render the 
surface resistant to protein adsorption (< 5ng/cm2) and implies that the bio-ligand RGD 
was presented at a density of 1.6 pmol/cm2 (Table 1). Similar results were obtained for 
the control peptide RDG. 
 
 
HAC attachment, Spreading Kinetics & Proliferation 
Phase contrast microscopy observation revealed that, as early as 10 min. after seeding, 
adult human articular chondrocytes (HAC) on RGD started to spread, while on TCPS they 
still showed a more round morphology. This impression was validated by following the 
spreading kinetic of HAC every 2 min., starting 5 min. after seeding onto the 
corresponding surface (see Fig. 2). On RGD, the maximal spreading speed (88±6 
µm2/min.) was 1.9-fold higher as compared to that on TCPS (46±4 µm2/min.; p < 10-5; U-
test Mann-Whitney, two tailed). Despite this initial difference, HAC attachment (24h after 
seeding) on RGD did not significantly differ from that on TCPS, while it was lower on 
PEG (4.7-fold) and RDG (5.6-fold) (Tukey HSD test: p < 0.009; see Fig. 3A). Phase  
 - 76 - 
contrast images confirmed attachment of HAC on TCPS and RGD and indicated a spread, 
fibroblastic cell morphology (Fig. 4). In contrast, on PEG and RDG, HAC attached to a 
very limited extent, and predominantly remained in suspension as clusters. The 
proliferation rate of HAC on RGD did not differ from that measured on TCPS, while it 
was lower on the bio-inactive surfaces PEG (2.9-fold) and RDG (3.1-fold) (p < 0.004; 
Tukey HSD test; see Fig. 3B). 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2: Initial spreading of human articular chondrocytes (HAC) on tissue culture polystyrene (TCPS) and on RGD-
functionalized PLL-g-PEG ( RGD). Immediately after seeding onto the corresponding surface, the spreading kinetic 
of HAC was followed by time lapse phase contrast microscopy every two min. during 18 min. Spreading was measured 
as footprint area (n=28 for each surface) and reported as median value in um2. The dashed tangential lines indicate 
maximal the slope mmax which was siginificantly different on the two substrates (the asterisk indidicates p = 3.4x10-5; 
U-test Mann-Whitney, two tailed). Cell outlines at each timepoint (up to min. 10) visualize an example HAC from each 
surface (RGD: upper row; TCPS: lower row) which matches with the indicated trend line (solid). Error bars represent 
the standard error. 
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Fig. 3: Attachment and proliferation of adult human articular chondrocytes (HAC) on tissue culture polystyrene 
(TCPS), RGD-functionalized PLL-g-PEG (RGD) and non-functionalized PLL-g-PEG (PEG). RGD peptide surface 
density was 1.6 pmol/cm2. A The number of attached cells was determined indirectly by counting the floating cells in 
the supernatant (alive and dead) and subtracting them from the number of inoculated cells. The attachment is expressed 
as percentage of the number of inoculated cells. B The proliferation rate of HAC is expressed as N doublings per day 
(during the two expansion steps). The asterisk indicates a significant difference vs. TCPS (n = 6 experimental replicates; 
p ≤ 0.009, Tukey HSD test). 
 
 
 
Fig. 4: Phase contrast images of adult human articular chondrocytes (HAC) during expansion on tissue culture 
polystyrene (TCPS), non-functionalized PLL-g-PEG (PEG), the scrambled sequence RDG-functionalized PLL-g-PEG 
(RDG) and the RGD-functionalized PLL-g-PEG (RGD). RGD and RDG peptide surface density was 1.6 and 1.7 
pmol/cm2 respectively. Scale bars correspond to 100 µm. 
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HAC Morphology & Motility During Cell Expansion 
The average footprint area (see Fig. 5A) of HAC growing on TCPS was 19% higher than 
on RGD (Two-way Anova: p = 0.014), while the average perimeter of HAC on TCPS 
(330±22 µm) was consistently lower than on RGD (424±27 µm; Two-way Anova: p < 
107). As a consequence, the average shape factor φA on RGD (see Fig. 5A) was 2.0-fold 
lower (Two-way Anova: p < 10-7) as compared to that of HAC expanded on TCPS. This 
morphological difference also became apparent by directly comparing the CLSM images 
(see Fig. 5 C&D). On both TCPS and RGD, a homogenous fluorescence signal could be 
seen throughout an entire HAC as actin appeared to be mostly organized into fine 
filamentous structures. Only rarely, thicker actin bundles, as they are typical for stress 
fibres, were evident. Regions of highest actin-signal intensities were located at the 
lamellipodia, as well as at the filopodia-like extensions. These extensions were the most 
distinctive morphological feature of HAC adherently growing on RGD as compared to 
TCPS.  
 
Time-lapse phase contrast microscopy revealed that on RGD cell motility (3.8±0.2nm/s, 
n=230) was approximately 20% lower than on TCPS (4.7±0.2nm/s, n = 209; p = 0.002; 
Student’s t-test, two tailed). The direction of HAC migration was judged by the 
distribution of centered cell trajectories and found to be isotropic on both RGD and TCPS 
(data not shown). 
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Fig. 5: Morphology of adult human articular chondrocytes (HAC) during expansion on tissue culture polystyrene 
(TCPS) and RGD-functionalized PLL-g-PEG (RGD). The graph in A) represents the average shape factor ΦA(white 
bars) and the average footprint area in um2 (black bars) of HAC on the corresponding substrate. The asterisk indicates a 
significant difference (n = 90 per surface; p < 0.0014, two-way ANOVA). The cartoon in B) visualizes shape factor 
values which can range from zero for starfish-shaped cells to one for perfectly round shaped cells. Representative 
confocal laser scanning microscopy images of HAC on C) TCPS and D) RGD show actin stress fibres (green) and 
nuclei (blue). Note the filopodia-like structures, which appear more frequent on RGD. Scale bar corresponds to 20 µm. 
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HAC De-Differentiation During Cell Expansion 
During expansion in monolayer, type II collagen mRNA expression of HAC on RGD was 
4.9-fold higher as compared to that on TCPS (p < 0.04; U-test Mann-Whitney, two tailed) 
while the level for type I collagen mRNA remained similar (see Fig. 6). Type X collagen 
was only upregulated in cells from Donor B (34-fold) and thus no significant difference 
was found on RGD vs. TCPS. 
On PEG, type II collagen mRNA was up-regulated 46-fold (p < 0.04; U-test Mann-
Whitney, two tailed). This up-regulation coincided with a 91-fold increase in type X 
collagen mRNA expression (p < 0.03; U-test Mann-Whitney, two tailed) while the 
expression level of type I collagen mRNA remained unaltered. 
 
 
 
 
 
 
 
Fig. 6: Type I (Coll I), II (Coll II) and X (Coll X) collagen mRNA expression levels of adult human articular 
chondrocytes (HAC) during expansion on RGD-functionalized PLL-g-PEG (RGD) or non-functionalized PLL-g-PEG 
(PEG) normalized vs. tissue culture polystyrene (TCPS, indicated by white dashed line). RGD peptide surface density 
was 1.6 pmol/cm2.Black bars represent m-RNA expression levels on of HAC after four weeks of culture on the 
corresponding substrate. Asterisks indicate a significant differences vs. TCPS (n = 6 experimental replicates; p < 0.05, 
U-test Mann-Whitney, two tailed). 
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HAC Re-Differentiation in Pellet Culture 
Pellets were generated with HAC expanded on TCPS or on RGD and cultured in 
chondrogenic medium for two weeks. 
The up-regulation of type II collagen mRNA during the expansion of HAC on RGD was 
not maintained in the subsequent pellet culture. Only for type X collagen mRNA a 
statistically significant (p < 0.004; U-test Mann-Whitney, two tailed) but rather limited 
up-regulation (1.7-fold) was found.  
HAC expanded on RGD generated pellets with 15% higher GAG content accumulation 
(6.3±0.2 µg/µg; p = 0.1, U-test Mann-Whitney, two tailed) than HAC expanded on TCPS 
(5.3±0.5 µg/µg). Additionally, sections of pellets from RGD expanded HAC stained 
slightly more intense for GAG (Safranin O staining) and type II collagen (Fig. 7). 
 
 
 
 
 
Fig. 7 (following page) : Histology of pellets generated from adult human articular chondrocytes (HAC) which have 
been cultured for two passages on either tissue culture polystyrene (TCPS) or RGD-functionalized PLL-g-PEG (RGD). 
RGD peptide surface density was 1.6 pmol/cm2. A) representative pellet sections stained red for glycosaminoglycans 
with Safranin O. The number at the lower right of each image shows the value for accumulated GAG/DNA in 
µg/µg(±SD, n = 4). B) representative pellet sections immunohistochemically labelled red for collagen II. Representative 
sections are displayed for each donor and surface type. As an overview, the insets present entire pellet sections. Scale 
bars correspond to 50 µm for the pellet sections and 500 µm for insets. 
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DISCUSSION 
In this in vitro study, we exploited the advantage of the PLL-g-PEG/PEG- RGD (RGD) 
model to restrict the interaction of human articular chondrocytes (HAC) with the culture 
substrate exclusively through the cell adhesion ligand RGD, even in the presence of 
serum. As compared to TCPS, RGD allowed for comparable attachment, proliferation and 
migration while supporting faster initial spreading but smaller final spreading area. The 
superior preservation of HAC chondrogenic phenotype in monolayer culture on RGD 
resulted in limited, yet consistent improvements in the post-expansion cartilage forming 
capacity in pellet cultures, although that was not reflected in the type II collagen gene 
expression. 
 
The amount of serum proteins measured on the PLL-g-PEG modified substrates was very 
low and fell below the detection limit range reported for the optical waveguide lightmode 
spectroscopy technique. (190) This protein resistant effect can be attributed to the 
architecture of the PEG brush. (191) Indeed, on PEG and RDG (scrambled cell adhesion 
sequence), HAC attached to a very limited extent and mostly remained suspended in the 
culture medium as clusters. The fact that on these bio-inactive surfaces cell attachment 
was not completely abolished could be explained by small local defects in the PLL-g-
PEG or PLL-g-PEG/PEG-RDG- layer, which likely permitted limited serum adsorption. 
These defects appeared to occur at a low frequency and merely allowed for cell anchoring 
but never for cell spreading. Only where PLL-g-PEG was modified with the cell adhesion 
ligand RGD, HAC attached and spread comparably to the way they do on TCPS. As RDG 
was not able to mediate the same effects, we assume that the effects observed in this study 
are specifically mediated by the bioligand RGD. Thus, the PLL-g-PEG/PEG-RGD culture 
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surface effectively allows for HAC/substrate interactions exclusively through RGD 
ligands, thereby circumventing the formation of a complex proteinaceous interface, even 
in presence of serum containing medium. 
 
Early after seeding, HAC spreading always appeared more advanced on RGD than on 
TCPS. This observation was confirmed by measuring an almost two fold higher initial 
spreading rate on RGD as compared to that on TCPS. Since the spreading area was 
smaller on RGD than on TCPS, the higher spreading rate on RGD was likely not due to a 
higher cell adhesion ligand density, but rather to a sterically more direct mode of 
interaction of HAC integrins with the surface bound RGD. This is consistent with the fact 
that the RGD ligand is displayed in front of an otherwise inert environment (PEG brush 
border), as opposed to the various different orientations (177) of randomly adsorbed 
serum proteins, where ligands can remain encrypted (e.g., within the FnIII modules of 
folded fibronectin (192)). Although cells have the ability to access these cryptic domains 
by applying cytoskeletal tension, (193) this active remodeling process of the protein 
adlayer would require longer time. Whether the faster spreading on RGD is really due to a 
more direct mode of interaction, would however require further investigations, beyond the 
scope of this study. 
 
HAC cultured on RGD and on TCPS attached and proliferated to an extent as previously 
reported for standard HAC culture (102;194). A drastically reduced attachment on the 
bio-inactive surfaces (PEG & RDG) coincided with a decreased proliferation rate, which 
is in line with findings for human dermal fibroblasts (186). Chondrocytes adhering to 
cartilage ECM-proteins highly express β1 integrins and knocking out these integrins in a 
mouse model led to decreased chondrocyte proliferation due to impaired G1/S transition 
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and cytokinesis (181). RGD partially activates α5β1 (195;196) but primarily αvβ3 
integrin receptor (135) and thus seems likely to have stimulated proliferation through 
integrin activated signalling. 
 
HAC cultured on RGD or TCPS assumed an elongated morphology (see Fig. 5), as 
confirmed by quantification of the shape factor (φA), which did not exceed the value of 
0.2. The lower shape factor on RGD than on TCPS does not reflect further elongation but 
can be attributed to the protrusive extensions which mainly contributed to the increased 
perimeter. Such distinctive morphological features remind of filopodia which have been 
reported to occur at the leading edge of motile cells (197). However, HAC motility on 
TCPS was found to be in the same range as reported for rabbit chondrocytes (198), and 
lower on RGD, where filopodia-like structures were primarily observed. 
 
Both the lower motility and the higher type II collagen mRNA expression of HAC 
expanded on RGD, as compared to TCPS, could be related to the reduced cell spreading 
area. In fact, cell spreading is associated with ROCK-mediated cytoskeletal tension (119) 
and is known to block chondrogenesis in mouse mesenchymal limb bud cells by 
inhibiting the expression of the transcription factor Sox9 (165). A reason for the reduced 
HAC spreading on RGD could be its lower bioactivity as compared to native ligands, 
where complementary or modulatory domains are present (135). In fact, FN, which 
readily adsorbs to TCPS (199), contains the synergistic binding site PHSRN on 9th type 
III repeat (FIII9) in addition to the RGD motif in the 10th type III repeat (FIII10). RGD is 
considered to be a poor FN mimic (135) as on its own it is not sufficient to fully activate 
α5β1 integrin but requires the synergy with PHSRN (111;200). Disturbing the 
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interdomain interaction of the FIII9-10 pair was reported to result in reduced spreading of 
baby hamster kidney cells and human endometrial stromal fibroblasts (137). 
 
The better maintenance of HAC chondrogenic phenotype on RGD resulted in consistent 
but rather marginal improvements of chondrogenesis during pellet culture, as evidenced 
by the slightly higher accumulation of GAG/DNA, staining intensity for GAG and type II 
collagen expression in the formed tissues. It is possible that enzymatic disruption of HAC 
adhesion to RGD (for establishing pellet cultures) degraded important cell surface 
proteins (201) and partially reset the instructive signal to HAC. In this regard, future 
investigations should circumvent the need for such a harvesting step. As an example, 
HAC could be expanded on an RGD-ligand restricted scaffold that could be directly 
continued into differentiation culture. Still, the presentation of RGD might have to be 
transient (during expansion), since modifying alginate with an RGD-ligand was 
previously found to inhibit MSC chondrogenesis (136;202). 
 
Beyond allowing control over the mode of cell interaction with a biomaterial interface, 
small ECM-fragments also offer to modify/tune the bioactivity of native proteins. The 
results of this study suggest that the limited bioactivity of RGD better supports the 
chondrogenic phenotype of proliferating HAC as compared to a complex proteinaceous 
adlayer containing native FN (TCPS). Thus, it would be intriguing to test whether tuning 
RGD-restricted HAC/substrate interactions could yield still higher type II collagen 
expression (as i.e. on PEG), while preserving its effect to promote proliferation (as i.e. on 
RGD). Approaches to tune HAC/RGD-restricted substrate interaction could involve 
changing the sequence of the peptide ligand (138), controlling its special array (112) or 
coupling it to substrates with different mechanical compliance than stiff TCPS (109). 
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CONCLUSION 
In summary, forcing HAC-substrate interactions through RGD peptides not only mediated 
instantaneous cell attachment but also supported cell migration, proliferation and 
maintenance of the post-expansion cartilage forming capacity. Assisting these processes 
with inductive/instructive biomaterials may be essential for improving in situ cartilage 
regeneration, stimulated by microfracturing (152;203). In microfracturing, the 
subchondral bone plate is penetrated by small perforations which allow the 
recruitment/infiltration of mesenchymal stromal cells (MSC) from the bone marrow 
(204). MSC have the potential to chondrogenically differentiate (156), but due to their 
low numbers they first need to proliferate in situ in order to possibly improve the final 
outcome (152). Thus, an RGD-ligand restricted biomaterial interface could be a valuable 
tool to assist microfracture stimulated cartilage regeneration. 
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Chapter III 
 
 
 
SUBSTRATE ELASTICITY 
MODULATES 
TGF BETA STIMULATED 
RE-DIFFERENTIATION OF 
EXPANDED HUMAN  
ARTICULAR CHONDROCYTES 
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ABSTRACT 
Culture of mesenchymal progenitor cells on substrates with different elasticity has been 
shown to modulate cell fate/commitment. We aimed this study at investigating, whether 
substrate elasticity modulates TGFβ-3 (TGF) stimulated chondrogenic re-differentiation 
of expanded/de-differentiated human articular chondrocytes (HAC). 
 
Expanded HAC from 4 donors (43-77 years) were seeded onto 2D substrates of different 
elasticity and induced to re-differentiate in a defined serum free medium containing or not 
TGF for 7 days. Type I collagen (CI) functionalized poly acrylamide (PA) films (100-150 
thickness) with a Young’s modulus of 0.26±0.08 kPa (soft), 21.32±0.79 kPa 
(intermediately stiff) and 74.88±5.13 kPa (stiff) were employed. CI coated tissue culture 
treated plastic was considered as an infinitely stiff substrate and HAC aggregate cultures 
served as a standard re-differentitation control. HAC cultured on the corresponding 
substrate were assessed for attachment, proliferation, morphology, mRNA (type I & II 
collagen), and protein (type II collagen) expression. 
 
Under re-differentiation conditions, HAC attached similarly on the different substrates 
and accomplished less than one total doubling within 7 days. On intermediately stiff to 
infinitely stiff substrates HAC assumed a fully spread fibroblastic morphology (shape 
factor φA = 0.23-0.27), whereas on the soft substrate, they remained more spherical (φA = 
0.35±0.02) and had a reduced spreading area (up to 3.2-fold). F-actin organization on the 
soft substrate was restricted cortically, while on the stiffer substrates, F-actin assembled 
into stress fibres. 
 
Type II collagen mRNA expression on the soft substrate was similar to that in aggregate 
culture and 18.1-fold higher than on infinitely stiff substrates. However, in absence of 
TGF, type II collagen mRNA remained at levels expressed by expanded/de-differentiated 
HAC. Strikingly, type II collagen protein expression was only detectable on the soft 
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substrates. Substrate elasticity modulated the re-differentiation response of expanded/de-
differentiated HAC to the chondrogenic stimulus TGF, and thus underscores mechanical 
compliance in combination with appropriate soluble signals to be an important parameter 
in designing biomaterials for cartilage repair. 
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INTRODUCTION 
Current visions in cartilage repair aim at moving from fibrocartilaginous to a more 
hyaline like repair tissue by combining autologous cells of different origins (in situ 
recruited or in vitro pre-cultivated) with repair supporting biomaterials (151). Therein, the 
role of a chondro-supportive biomaterial within a cartilage defect is seen to enhance the 
onset of chondrogenic differentiation of the progenitor cells and to protect/modulate the 
newly formed tissue (152). 
Apart from controlling ligand identity, density and presentation, which determine 
biomaterial/cell interaction(108), substrate elasticity has emerged as an important, 
insoluble, mechanical cue and has been shown to influence the phenotype of several 
members of the mesenchymal lineage, including fibroblasts (143;144), myoblasts 
(145;146) and osteoblasts (110). Moreover Mesenchymal stem cells (MSC) have been 
found to specify lineage and to commit to phenotypes with extreme sensitivity to tissue 
level elasticity. Soft substrates which mimic brain were neurogenic, stiffer substrates that 
mimic muscle were myogenic and comparatively stiffer substrates that mimic collagenous 
bone, proofed to be osteogenic. Moreover, the insoluble mechanical cue was shown to be 
additive to chemical/soluble induction of differentiation (109). 
 
Chondrocytes are considered to have a primitive precursor termed “the mechanocyte” 
which suggests, that they have inherited the ability to respond to mechanical stimuli 
(205). Indeed, chondrocytes express several members of the integrin family which, apart 
from mediating adhesion, function as mechanoreceptors that transmit information from 
the extracellular matrix (ECM) into the cell, through the activation of cell signalling 
pathways(206). This integrin mediated perception of the ECM has been found to play a 
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crucial role in regulating chondrocyte morphology, motility, proliferation as well as 
differentiation (181;182). 
Although depending on the type of cell, increased matrix stiffness generally leads to an 
increased protein phosphorylation, and stress fibre assembly (144;207). In line with this 
general rule, porcine chondrocytes flattened and spread on stiff substrates (100kPa) while 
they retained their typical round appearance on soft (4kPa), compliant matrices (208). 
 
The importance of morphology on chondrocyte function started to be recognized around 
30 years ago (209). Several findings reported the chondrocyte phenotype to be strongly 
depending on its cell shape, which changes from fibroblastiod to rounded/polygonal 
during cartilage development and is associated with a cortical actin filament organization, 
as well as the expression of extra cellular matrix proteins such as type II collagen and 
large proteoglycans (i.e. aggrecan) (210;211). Monolayer expansion of chondrocytes, 
isolated from adult cartilage, can revert this differentiation process and leads to de-
differentiated chondrocytes which cease the production of large proteoglycans and type II 
collagen (97;98) and switch to the synthesis of type I collagen, fibronectin (FN), and 
small non-cartilaginous proteoglycans (98;99). 
As a consequence considerable research efforts have focused on developing reliable 
procedures to maintain a round morphology in cultured chondrocytes. Conditions that 
support a round cell morphology and expression of the chondrocytic phenotype include 
culture in suspension (101;212), in agarose (96), in collagen gels (124), in alginate beads 
(213), and the disruption of the actin cytoskeleton by Cytochalasin D (214;215). Most 
recently, soft (4kPa) type I collagen coated polyacrylamide (PA) gels have also been 
demonstrated to induce a round morphology in porcine chondrocytes (208). However, in 
comparison to stiffer substrates, the better support of the chondrogenic phenotype by soft 
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PA gels was limited and paralleled by reduced proliferation. Proliferation is known to 
lead to rapid de-differentiation in chondrocytes (95) and thus, may have clouded the 
analyis of matrix elasticity as a direct influence on the maintenance of the chondrogenic 
phenotype. 
 
The use of specific factors during monolayer expansion of HAC has been shown to 
accelerate the process of de-differentiation, and induces HAC to acquire a differentiation 
plasticity which is similar to that of mesenchymal progenitor stem cells (100). Culturing 
aggregates (suspension or pellet culture) of expanded/de-differentiated HAC in a medium 
containing the strong chondrogenic stimulus TGFβ-3 (TGF), allows for re-induction of 
chondrogenic differentiation (101;102). Thus, expanded/de-differentiated HAC are not 
only of clinical relevance but, owing to their plasticity, also serve as a potent model to 
investigate processes involving fate commitment and the maintenance of mesenchymal 
progenitor cells. 
 
Given the mechano-sensitivity of chondrocytes in general and the differentiation 
plasticity of expanded/de-differentiated HAC in specific, we hypothesized that matrix 
elasticity as an insoluble signal allows to control the morphology of expanded/de-
differentiated HAC and thereby permits to modulate their re-differentiation stimulated by 
the soluble chondrogenic differentiation signal TGF. 
 
Among different models for investigating the substrate elasticity influence on cell 
behaviour, polyacrylamide (PA) has emerged as an important tool since it can be easily 
adjusted in elasticity by varying the concentration of the monomer acrylamide (AA) and 
the crosslinker N,N’-methylenbisacrylamide (BIS). PA itself is almost completely inert 
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for cell adhesion, but can be functionalized by covalently grafting proteins to its surface 
(216). This offers the advantage to restrict cell/substrate interaction to a selected type of 
ligand. For the present study, type I collagen (CI) was chosen as it contains the cell 
adhesion peptide sequence Arg-Gly-Asp (RGD) (217), has been used to study the 
influence of matrix elasticity on the lineage specification of mesenchymal stem cells 
(109) and plays an important role during limb bud chondrogenesis (218). 
 
To test our hypothesis, expanded/de-differentiated HAC were seeded onto 2D substrates 
of different elasticity and induced to re-differentiate in a defined serum free medium 
containing or not TGFß-3 for 7 days. CI functionalized PA films (100-150 µm thickness) 
with a Young’s modulus of 0.26±0.08 kPa (soft), 212±0.79 kPa (intermediately stiff) and 
74.88±5.13 kPa (stiff) were employed. CI coated tissue culture treated plastic was 
considered as an infinitely stiff substrate and HAC aggregate cultures served as a standard 
re-differentiation control. HAC cultured on the corresponding substrate were assessed for 
attachment, proliferation, morphology and expression of Sox-9 transcription factor, type I 
and II collagen mRNA and type II collagen protein. 
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METHODS 
 
Substrate Preparation 
Poly acrylamide (PA) gels of three different contrasting compositions, were cast onto 3-
(trimethoxysilyl)-propyl methacrylate (Sigma-Aldrich, Buchs, CH) activated glass slides, 
and functionalized with type I collagen following a protocol adapted from Beningo et al. 
2002 (219;220). Using coverglass (No. 1, Medite, CH) spacers, the gel thickness was set 
to a thickness ranging from 100 to 170 µm (confirmed by cryo SEM, data not shown). 
According to the time course measurements of the shear storage modulus G’, the 
polymerization was near complete 20 min. after initiation (see Fig. 1). Based on this 
finding, > 4 hours were considered to be safe for the polymerization to complete. 
Subsequently, the glass immobilized PA gels were washed with autoclaved MilliQ water 
followed by 50 mM HEPES pH 8.5 (Sigma-Aldrich, Buchs, CH). The PA gels were 
covered with 1 mM sulfo-SANPAH (heterobifunctional protein crosslinker, ProteoChem, 
USA) in 50 mM HEPES pH 8.5, UV activated (350 nm, 8 min., distance: 6 cm). This step 
was repeated once before thoroughly washing the substrates with PBS (Gibco, UK). 
Immediately after, the activated PA gels were functionalized with 0.2 mg/ml type I 
collagen (CI, rat tail, BD, UK) at 4°C over night. The density of surface-bound CI is 
independent of PA gel stiffness (221) and does not alter the elastic modulus of the 
substrate (145). 
All substrates were UV light sterilized (30 min. at a sterile work bench). CI functionalized 
PA gels were washed and stored in PBS until further use. 
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Substrate Characterization by Rotational Rheometry 
The polymerization time course (20 min, see Fig. 1) of three different mixtures consisting 
of acrylamide (AA, monomer) and N,N’-methylenbisacrylamide (BIS, crosslinker) was 
followed in situ in a rotational rheometer (Physica MCR 501, Anton Paar, Graz, Austria), 
fitted with a 50 mm diameter parallel plate (PP50). Shear storage modulus (G’, increases 
with the progressing degree of polymerization & crosslinking) measurements were 
conducted at room temperature (25°C), an oscillation frequency of 1 Hz and an amplitude 
of 1%. The volume for polymerization was 2 ml and initiated with 30 µl of 10% amonium 
persulfate (APS) and 30 µl of 10% tetramethylethylenediamine (TEMED). The 
concentrations for AA_BIS were: 5%_0.003%, 10%_0.2%, 20%_0.3% as described 
above and the duplicates prepared independently. To prevent drying, polymerization was 
performed in a humidified atmosphere. All of the three distinct AA/BIS compositions 
displayed variable patterns during the lag phase in which G’ was negligibly small (< 0.1 
Pa). Following the lag phase, G’ increased monotonically but ceased less than 5 min. after 
initiation of polymerization. After ~20 min. of polymerization, each of the three AA/BIS 
compositions reached its distinct plateau value (see Fig. 1 A). Degassing the AA/BIS 
solution prior to polymerization neither changed the polymerization pattern (G’ time 
course), nor the final plateau levels for G’ (data not shown). 
To measure PA under conditions more representative of in vitro cell culture conditions, 
PA slabs of 4 mm thickness were polymerized for >4h and swelling equilibrated in PBS 
at room temperature > 24h. Shear storage and loss modulus (G’ and G’’) measurements 
were performed using the same rheometer settings as described above. 
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The elastic modulus describes the ability of a material to deform elastically (strain) when 
a force (stress) is applied to it, is quantified as a ratio of stress to strain and expressed in 
Pascals (Pa). Depending on the mode of measurement, the elastic modulus is commonly 
reported either as Young’s modulus (E, uniaxial stress over the uniaxial strain, e.g. 
indentation) or shear storage modulus (G’, deformation of shape at constant volume, e.g. 
shearing), given the Hooke’s law holds for the material described. Since PA hydrogels 
have a vanishingly low viscous component (shear loss modulus G’’) (222) their elasticity 
can adequately be described by either E or G’. As a fact, the elastic component of PA (G’) 
was always higher (6.9 to 161.4-fold) compared to its viscous component G’’. The shear 
storage modulus would be appropriate in the context of this work, since cells like i.e. 
fibroblasts are known to probe substrate mechanoproperties by shearing (223). However, 
the Youngs’ modulus was preferred based on its wide spread use in the field of 
mechanobiology. 
 
 Tab.1: Rheology of polyacrylamide (PA) gels. The shear storage modulus (G’) and the shear loss modulus (G’’) of PA 
gels with three different acrylamide (AA, monomer)/N,N’-methylenbisacrylamide (BIS, crosslinker) compositions was 
measured by a rotational rheometer (Physica MCR 501, Anton Paar, Graz, Austria) fitted with a 50 mm diameter 
parallel plate (PP50). Measurements were conducted at an oscillation frequency of 1 Hz and an amplitude of 1% at 
37°C in a humidified chamber. The PA gels were measured either 20 min. after initiation of polymerization directely in 
the rheometer (n=2) or after swelling equilibration (in PBS at room temperature over night, n = 4). The Young’s 
modulus (E), which is widely spread to describe substrate elasticity, was computed from the dynamic modulus G = 
G’+G’’ according to E = 2G’(1+ν). The Poisson ratio (ν) for PA is 0.464 (224) which is close to that of ideal rubber 
like materials (0.5). The values are reported as mean ± standard deviation. 
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Cell Culture 
Full thickness human articular cartilage samples were collected within 24 hours post 
mortem from the femoral lateral condyle of four donors (43 to 77 years), with no history 
of joint disease, after obtained informed consent, following protocol approval by the local 
ethical commitee (No. 78/07). HAC were isolated upon 22-hour incubation at 37 °C in 
0.15% type II collagenase and resuspended with Dulbecco’s modified Eagle’s medium 
(DMEM) containing 4.5 mg/ml D-glucose, 0.1 mM non-essential amino acids, 1 mM 
sodium pyruvate, 10 mM HEPES buffer, 100 U/ml penicillin, 100 µg/ml streptomycin, 
and 0.29 mg/ml L-glutamine, supplemented with 10% FBS (all from Gibco, UK) 
(complete medium, CM). 
HAC were expanded in CM supplemented with 1 ng/ml TGF-ß1, 5 ng/ml FGF-2, 10 
ng/ml PDGF-BB (expansion medium, all from R&D, UK) in a humified 37°C/5% CO2 
incubator. These specific growth factors have previously been shown to enhance HAC 
proliferation and post-expansion redifferentiation capacity (102). HAC were detached at 
confluency (passage 1) by a treatment with 0.3% type II collagenase, followed by 0.05% 
trypsin/0.52 mM EDTA (Gibco, UK) and re-plated at a density of 5 x103 cells/cm2 for the 
second expansion step. After passage 3, expanded HAC were taken into chondrogenic re-
differentiation culture. 
 
Chondrogenic Re-differentiation culture 
The chondrogenic re-differentiation of expanded HAC was stimulated using a chemically 
defined, serum-free medium (SFM), which consists of DMEM containing 4.5 mg/ml D-
glucose, 0.1 mM non-essential amino acids, 1 mM sodium pyruvate, 10 mM HEPES 
buffer, 100 U/ml penicillin, 100 µg/ml streptomycin, and 0.29 mg/ml L-glutamine (all 
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Gibco, UK) supplemented with ITS+1 (10 µg/ml insulin, 5.5 mg/ml transferrin, 5 ng/ml 
selenium, 0.5 mg/ml bovine serum albumin, 4.7 mg/ml linoleic acid), 1.25 mg/ml human 
serum albumin, 0.1 mM ascorbic acid 2-phosphate and 10-7 M dexamethasone (all Sigma 
Chemical, USA) and 10 ng/ml TGF-β1 (R&D, UK) (chondrogenic medium) (100;189). 
To investigate the influence of substrate stiffness on HAC re-differentiation, expanded 
HAC were cultured for 7 days on type I collagen coated PA gels of different stiffness at 
density of 2 x 104 cells/cm2. Aggregate cultures were prepared by culturing HAC at the 
same density on bare (w/o CI) tissue culture plastic (TCPS). Due to the absence of serum 
proteins, HAC display moderate initial substrate adhesion and preferentially stick to each 
other rather than to the substrate. After one day of re-differentiation culture, nearly all 
HAC have detached from the substrates and float in suspension as cellular aggregates 
similarly as described previously by Wolf et al. (2008) (101). 
 
Attachment & Proliferation 
The number of adherent HAC (N0) was determined from representative phase contrast 
light microscopy images and expressed as percentage of the number of theoretically 
seeded cells. After 7days of re-differentiation culture, the number of adherent HAC (N1) 
was counted again (as described above) to assess proliferation which was expressed by 
the total number of doublings: log2 (N1/N0). 
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Cell morphology 
HAC morphology and the degree of spreading were determined after 24hours of re-
differentiation culture. The cell shape factor φ (Eq. 1) (186;187) was calculated according 
to: 
 
        (1) 
 
The area A and the perimeter p required for calculating the shape factor φ were 
determined from phase contrast images using Image J version 1.37 (188). Rounded cells 
with high area-to perimeter ratio assume shape factor φ values close to 1, whereas 
starfish-shaped cells have a shape factor φ near 0. 
 
Fluorescence Labelling, Acquisition and Analysis 
After fixation in 4% (w/w) formaldehyde in phosphate buffer pH 7.4 (Univerity Hospital 
Pharmacy Basel, Switzerland) at 4°C over night, HAC were rinsed with PBS three times 
prior to a 10 min. permeabilization on ice with a solution containing 0.02% (w/w) Triton 
X100 (Sigma-Aldrich, Switzerland). Immediately after aspiration of the permabilization 
solution, the specimen were blocked for 1 hour at room temperature in PBS containing  
30 mg/ml BSA (Sigma-Aldrich, Switzerland). Then, the specimens were rinsed with 
labelling buffer (LB) containing 15 mg/ml BSA in PBS and incubated with the primary 
antibody for 1h at room temperature. Subsequently, the specimens were rinsed with LB 
four times for 5 min. each and incubated with the secondary antibody for 1h at room 
temperature. Finally, the slides were washed again with LB four times for 5min. each, 
2p
Aπ4
=φ
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rinsed with autoclaved milliQ water, mounted with Aqueous Mounting Media (AbD 
SeroTec, Oxford, UK) and sealed with Klarlack (Lady Manhattan Cosmetics, Germany).  
All antibodies/labelling agents were diluted in LB. Vinculin was labelled with a primary 
monoclonal mouse antibody (Sigma-Aldrich, Switzerland; clone: hVIN-1; dilution: 
1:400) followed by a Cy3 conjugated IgG goat anti-mouse secondary antibody (Acris 
Antibodies, Herford Germany; dilution: 1:800).  
F-actin was detected with Alexa488 conjugated phalloidin (Invitrogen, Oregon USA; 
dilution: 1:400) and nuclei stained with DAPI (Invitrogen, Oregon USA; 4',6-diamidino-
2-phenylindole; dilution: 1:48’000). 
Sox-9 transcription factor was labelled with a monoclonal mouse antibody (Lubio-
Science, Switzerland, clone: 3F11; dilution: 1:200) followed by an Alexa546 conjugated 
IgG1 goat anti- mouse secondary antibody (Lubio-Science, Switzerland, dilution: 1:200). 
Fluorescence images were acquired on a Zeiss LSM 710 TYPE (Zeiss, Wetzlar, 
Germany) confocal laser scanning microscope under constant conditions using either a 
40x or a63x immersion objective. Eight bit z-stack images were recorded in three 
different, regions of each substrate. 
To quantify type II collagen expression pixels with a fluorescence intensity higher than 20 
(arbitrary units) were counted on each z-plane, using the Zen2008 software (version 5.0, 
Zeiss MicroImaging GmbH). The z-stack with the highest florescent counts was taken 
and normalized vs. the number of DAPI stained nuclei in the corresponding stack. 
 
Gene Expression Analysis 
After 7 days of re-differentiation culture, HAC were harvested (as described above; using 
collagenase and trypsin). RNA was extracted from the obtained cell pellets with 250 µl 
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Trizol (Life Technologies, Basel, CH) according to the manufacturer’s instructions. 
Extracted RNA was treated with DNAse following the instructions of the RNeasy Kit 
(Ambion, Austin TX). cDNA was generated from total RNA using reverse-transcriptase 
Stratascript (Stratagene) in the presence of dNTP and DTT. Real-time PCR reactions 
were performed and monitored using the ABI prism 7700 Sequence Detection System 
and the Sequence Detector V program (Perkin-Elmer Applied Biosystems). cDNA 
samples were analyzed for type I and II collagen and for the housekeeping gene (18S 
ribosomal RNA), using previously described sequences of primers and probes (100). Each 
cDNA sample was assessed in duplicate and the collagen mRNA expression levels were 
normalized to the corresponding 18S rRNA levels. 
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RESULTS 
 
 
 
 
 
 
 
 
 
Substrate Characterization 
The elasticity of swelling equilibrated polyacrylamide (PA) gels was determined by 
rotational rheometry, measuring the dynamic shear modulus (G) which consists of the 
shear storage modulus (G’) and the shear loss modulus (G’’, see Fig. 1 and Tab. 1). The 
dynamic shear modulus (G = G’ + G’’) was converted into the Young’s modulus (E = 
2G’(1+ν)), which is more widely spread to describe substrate elasticity and thus referred 
to hereafter (see Tab. 1). For the Poisson ratio (ν) a value of 0.464 was assumed as it has 
been reported for PA by others (224). 
Based on the mechanical compliance of the corresponding type I collagen (CI) 
functionalized PA, the substrates employed in this work are referred to as 0.3kPa (soft), 
21kPa (intermediately stiff) and 75kPa (stiff). TCPS coated with CI (TCPS w/ CI) was 
considered to be an infinitely stiff substrate. 
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Fig. 1 Characterization of polyacrylamide substrate elasticity. (A) Time course of shear storage modulus (G’, Pa) in 
polymerizing acrylamide (PA) mixtures. The polymerization time course (20 min.) of three different mixtures 
consisting of acrylamide (AA, monomer) and N,N’-methylenbisacrylamide (BIS, crosslinker) was followed in situ in a 
rotational rheometer (Physica MCR 501, Anton Paar, Graz, Austria), fitted with a 50 mm diameter parallel plate (PP50). 
Measurements were conducted at an oscillation frequency of 1 Hz and an amplitude of 1% at 37°C in a humidified 
chamber. The volume for polymerization was 2 ml and initiated with 30 µl 10% amonium persulfate (APS) and 30 µl 
10% tetramethylethylenediamine (TEMED). The concentrations for AA_BIS were: 5%_0.003% (open circles), 
10%_0.2% (grey triangles), 20%_0.3% (black diamonds) and the duplicates prepared independently. Following the lag 
phase, G’ increased monotonically but ceased less than 5 min. after initiation of polymerization. After ~20 min. of 
polymerization, each of the three AA/BIS compositions reached its distinct plateau value. (B) G’ comparison of in situ 
polymerized PA (20 min. after initiation, black bars; n = 2) and swelling equilibrated PA (in PBS at room temperature 
over night, white bars, n = 4). Swelling equilibrated PA displayed G’ values which were 33 to 85% lower compared to 
the corresponding in situ polymerized PA. Error bars represent standard deviation. 
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HAC Attachment and Proliferation 
Phase contrast images taken 24 hours after seeding expanded/de-differentiated HAC in 
chondrogenic medium revealed a homogenous cell distribution (see Fig. 2). HAC 
attachment was comparable on of the three different PA substrates, but 17 to 28% lower 
(see Fig. 3, Kruskal Wallis, Conover, p ≤ 0.05) than on TCPS w/ CI. Throughout the 7 
days of HAC cultivation in chondrogenic medium, proliferation remained below one total 
doubling and was similar on the soft (0.20±0.17 total doublings) and the infinitely stiff 
substrate (0.25±0.16 total doublings). 
 
Fig. 2 Representative phase contrast images of expanded/de-differentiated adult human articular chondrocytes (HAC), 
24 hours after seeding onto the corresponding substrate, in chondrogenic medium. 0.3, 21 and 75kPa indicate the 
substrate elasticity (Young’s modulus) of the three contrasting, type I collagen functionalized polyacrylamide 
substrates. Tissue culture treated plastic coated with type I collagen (TCPS w/ Col I) served as an infinitely stiff control. 
Scale bar: 200 µm. 
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Fig. 3 Attachment of expanded/de-differentiated adult human articular chondrocytes (HAC) 24 hours after seeding onto 
the corresponding substrate, in chondrogenic medium. 0.3, 21 and 75kPa indicate the substrate elasticity (Young’s 
modulus) of the three contrasting, type I collagen functionalized polyacrylamide substrates. Tissue culture treated 
plastic coated with type I collagen (TCPS w/ Col I) served as an infinitely stiff control. The number of adherent cells 
was determined from representative phase contrast light microscopy images and expressed as percentage of the number 
of initially seeded cells. The asterisks indicate significant differences (Kruskal-Wallis paired (Conover); p= * < 0.05 
and *** < 0.001; n = 6). 
 
 
HAC Morphology 
In chondrogenic differentiation medium, a rounded morphology and a limited spreading 
were characteristic features of HAC, cultured on a soft substrate (see Fig. 2). 
Contrastingly, on intermediately to infinitely stiff substrates, HAC were fully spread and 
assumed an average spreading area which was more than 3.2-fold higher than on the soft 
substrate (see Fig. 4, One-Way ANOVA, Tukey HSD; p < 0.001). That on the soft 
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substrates, HAC tended to assume a round morphology was also reflected by the 
shapefactor ΦA, which was 40 to 50% higher than on intermediately to infinitely stiff 
substrates (see Fig. 4, One-Way ANOVA, Tukey HSD; p < 0.001). Despite these 
differences, the average spreading area and shape factor of HAC on intermediately stiff to 
infinitely stiff substrates was found to be similar. 
 
 
 
 
 
 
 
Fig. 4 Average area (A) and shape factor ΦA (B) of expanded/de-differentiated adult human articular chondrocytes 
(HAC), 24 hours after seeding onto the corresponding substrate, in chondrogenic medium. 0.31, 21 and 75kPa indicate 
the substrate elasticity (Youngs’ modulus) range of the three contrasting, type I collagen functionalized polyacrylamide 
substrates. Tissue culture treated plastic coated with type I collagen (TCPS w/ Col I) served as an infinitely stiff control. 
The shape factor was computed from the cell area and perimeter and can range from zero for starfish-shaped cells to 1 
for perfectly round shaped cells. Area and perimeter of adherent cells was measured on representative phase contrast 
light microscopy images. The asterisks indicate significant differences (One-Way ANOVA, Tukey HSD; p = *** < 
0.001; n ≥ = 55). 
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HAC Actin Cytoskeleton and Focal Adhesions 
Fluorescence microscopy of HAC labelled for F-actin and vinculin showed that the 
morphology observed by phase contrast microscopy (after 24 hours) was maintained after 
7 days of re-differentiation culture (see Fig. 5). On the soft substrate, HAC remained 
spherical with F-actin mainly localized cortically. On intermediately stiff to stiff substrates 
however, HAC were spread, flattened and displayed a fibrillar F-actin organization into 
stress fibres. On all substrates, vinculin was dispersed throughout the entire cytoplasm but 
appeared most intense in the perinuclear region. Aggregations of vinculin into small 
clusters were detected in lamellipodial regions of HAC cultured on intermediately stiff to 
stiff substrates. On the latter, HAC in confluent spots displayed more actin stress fibres 
than cells which were more isolated. Moreover, actin stress fibres appeared more aligned 
and distinct on stiff as compared to intermediately stiff substrates, where F-actin was more 
diffuse throughout the cytoplasm (see Fig. 6). 
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Fig. 5 Representative confocal laser scanning microscopy images (maximum projection) of expanded/de-differentiated 
adult human articular chondrocytes (HAC), labelled for F-actin (green), vinculin (red) and nuclei (blue). HAC were 
induced to re-differentiate for 7 days in chondrogenic medium, on substrates of contrasting elasticity (Young’s 
modulus) which in (A, B) was 0.31kPa, for (C, D) 21kPa and 75kPa in (E, F). Images in the right column show details 
(indicated by the white arrow) of the corresponding image to their left. (B) Shows a merge and the separate channels of 
a mid section through a single HAC with spherical morphology (as indicated by the arrow in image A). Scale bars are 
50µm for the left column and 10µm for the right column 
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Fig. 6 Representative confocal laser scanning microscopy images (maximum projection) of expanded/de-differentiated 
adult human articular chondrocytes (HAC), labelled for F-actin (green), vinculin (red) and nuclei (blue). HAC were 
induced to re-differentiate for 7 days in chondrogenic medium, on substrates on intermediately stiff (A: 21kPa) and stiff 
(B: 75kP) polyacrylamide substrates. HAC in more confluent regions formed more actin stress fibres than isolated cells. 
Moreover, actin stress fibres and aggregates of vinculin were more distinct on the stiffer than on the intermediately stiff 
substrate. Scale bar: 20µm. 
 
 
Sox-9 Expression 
After 7d of culture in chondrogenic medium on the corresponding substrates, HAC were 
immuno-labelled for transcription factor Sox-9 (see Fig. 8). Generally, frequency and 
intensity of nuclear Sox-9 localization was heterogeneous throughout the HAC 
population, but most frequent and intense in HAC cultured on the soft substrate. This also 
coincided with higher cytoplasmic concentrations as compared to in HAC cultured on 
intermediately stiff and the stiff PA substrate. 
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Fig. 7 Representative confocal laser scanning microscopy images of human articular chondrocytes (HAC) labelled for 
Sox-9 (red) and nuclei (blue). (A, B) HAC after expansion (passage 3) on infinitely stiff glass substrates. (C,D) 
Expanded/de-differentiated HAC after 7 days of re-differentiation culture in chondrogenic medium, on infinitely stiff 
glass substrates. Since Sox-9 expression was heterogeneous throughout the population, two images are shown 
representing lowest (left column) and highest Sox-9 expression (right column) for each condition. The presented images 
are midsections through the nucleus. Single planes were acquired at the z-level of highest Sox-9 intensity. Scale bar: 
50µm. 
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Fig. 8 Representative confocal laser scanning microscopy images of expanded/de-differentiated human articular 
chondrocytes (HAC), labelled for Sox-9 (red) and nuclei (blue). HAC were induced to re-differentiate for 7 days in 
chondrogenic medium, on substrates of contrasting elasticity (Young’s modulus) which in (A, B) was 0.31kPa, for (C, 
D) 21kPa and 75kPa in (E, F). Since Sox-9 expression was heterogeneous throughout the population, two images are 
shown representing lowest (left column) and highest Sox-9 expression (right column) for each condition. The presented 
images are midsections through the nucleus. Single planes were acquired at the z-level of highest Sox-9 intensity. Scale 
bar: 50µm. 
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Gene Expression  
Expanded/de-differentiated HAC cultured for 7 days on the corresponding substrate were 
analyzed for type I and II collagen mRNA expression (see Fig. 9). In control experiments, 
where TGF was omitted from the chondrogenic medium, type II collagen mRNA 
remained at levels comparable with that of expanded/de-differentiated HAC. 
Contrastingly, type I collagen mRNA was lower on the PA substrates and in aggregates 
(3.9 to 9.6-fold) but on TCPS w/CI also remained at levels comparable with that of 
expanded/de-differentiated HAC. 
 
 
 
Fig. 9 Type II (A) and I (B) collagen mRNA expression levels of expanded/de-differentiated adult human articular 
chondrocytes (HAC) after 7 days of culture in chondrogenic medium without (white bars) or with (black bars) TGF. 
0.31, 21 and 75kPa indicate the substrate elasticity (Youngs’ modulus) range of the three contrasting, type I collagen 
functionalized polyacrylamide cell culture substrates. Tissue culture treated plastic coated with type I collagen (TCPS 
w/ Col I) served as an infinitely stiff and HAC aggregate cultures (Aggr.) as positive controls. All values are normalized 
vs. the housekeeping gene 18S and the dashed line represents the mRNA expression level in expanded/de-differentiated 
HAC. Asterisks above the brackets indicate a significant differences between two corresponding bars (Kruskal-Wallis 
paired (Conover); p= * < 0.05 and ** < 0.01; n = 15, 4 donors). Open circles above the white bars indicate a significant 
difference vs. (+) TGF on the same substrate (Mann-Whitney, U-test, two tailed; n = 4, p < 0.05). 
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Inclusion of TGF in the chondrogenic medium (standard) had a strong general effect on 
type II collagen mRNA expression in HAC (Mann-Whitney, U-test, two tailed; p = 
6.0x10-6) and despite for the infinitely stiff substrate, it induced an up-regulation ranging 
from 459-fold on intermediately stiff substrates to 3642-fold in HAC aggregates (Kruskal-
Wallis paired (Conover); p < 0.05). Although less dramatic, TGF also had a general effect 
on type I collagen mRNA expression (Mann-Whitney, U-test, two tailed; p = 1.5x10-4) 
and induced an up-regulation in HAC cultured on soft (12.2-fold) and intermediately stiff 
substrates (6.2-fold; Kruskal-Wallis paired (Conover); p < 0.05). 
Type II collagen mRNA expression by HAC after 7d of culture in chondrogenic medium 
on the soft substrate was similar to that in aggregate culture and 6.4 to 18.1-fold higher 
than on stiff and infinitely stiff substrates (Kruskal-Wallis paired (Conover); p < 0.05). 
While intermediately stiff substrates still allowed for a 6.2-fold higher type II collagen 
mRNA expression (Kruskal-Wallis paired (Conover); p < 0.05), no difference was found 
between the stiff PA substrate and the infinitely stiff TCPS w/ CI. Type I collagen mRNA 
expression was not altered by substrate stiffness and remained at levels comparable to that 
in expanded/de-differentiated HAC. However the absolute mRNA expression level of 
type I collagen was more than 514-fold higher than that of type II collagen. 
 
Type II Collagen Protein Expression 
Expanded/de-differentiated HAC cultured for either 7 or 14 days on the corresponding 
substrate were analyzed for type II collagen protein expression (see Fig. 10 & 11, data 
adapted from master thesis Andreas Trüssel 2010 (225)). Fluorescent staining in the form 
of intracellular granules could only be detected in HAC cultured on soft substrates. 
Surprisingly, after 14 days of culture the fluorescent intensity (see Fig. 11, data adapted 
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from master thesis Andreas Trüssel 2010 (225)) tended to be lower as compared to after 7 
days. On the intermediately to infinitely stiff substrates, the fluorescence signal remained 
on levels comparable to that in negative control staining (secondary antibody only). 
 
Fig. 10 Representative confocal laser scanning microscopy images (maximum projection) of expanded/de-differentiated 
adult human articular chondrocytes (HAC), labelled for type II collagen (red) and nuclei (blue). HAC were induced to 
re-differentiate for 7 days in chondrogenic medium, on substrates of contrasting elasticity. The substrate elasticity 
(Young’s modulus) in (A) is 0.3kPa, for (B) 21kPa, 75kPa in (E) and infinitely stiff in (C; glass coated with type I 
collagen). Scale bar: 50µm. Data adapted from master thesis A. Trüssel 2010 (225). 
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Fig. 11 Type II collagen expression of expanded/de-differentiated adult human articular chondrocytes (HAC). HAC 
were induced to re-differentiate for 7 days in chondrogenic medium, on substrates of contrasting elasticity. The 
substrate elasticity (Young’s modulus) in (A) is 0.3kPa, for (B) 21kPa, 75kPa in (E) and infinitely stiff in (C; glass 
coated with type I collagen). The dashed line represents the fluorescence signal in HAC that were stained with the 
secondary antibody only (negative control; background fluorescence). After thresholding, the number of pixels were 
counted from confocal laser scanning microscopy images (maximum projection) of type II collagen labelled HAC, and 
expressed as kilopixels normalized vs. the number of nuclei. Scale bar: 50µm. Data adapted from master thesis A. 
Trüssel 2010 (225). 
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DISCUSSION 
 
Using type I collagen coated PA substrates of contrasting stiffness, (0.3kPa: soft, 21kPa: 
intermediately and: 75kPa stiff), we investigated the influence of substrate elasticity on 
the re-differentiation of expanded/de-differentiated HAC. The soft substrates allowed for 
attachment comparably to the intermediately to infinitely stiff substrates, but supported a 
spherical morphology, from which actin stress fibres and focal complexes were absent. 
Moreover, HAC on soft substrates displayed highest Sox-9 nuclear translocation and type 
II collagen expression (mRNA and protein). 
 
Attachment & Proliferation 
The comparability of the PA substrates with regard to adhesive ligand presentation was 
reflected by the similar degree of HAC attachment thereon. That in contrast to PA, HAC 
attachment on TCPS w/ CI was higher, could be associated with the different modes of 
protein immobilization on the two substrates. While PA was functionalized with CI by 
chemisorption (sulfo-SANPAH crosslinker), TCPS was coated with CI by physisorption. 
Both approaches are known to influence native biological protein activity and likely do so 
in a distinct but unpredictable manner (for review see (178)) and thus prompts for 
carefully comparing TCPS and PA in this regard. However, considering substrate 
elasticity to be the key parameter, protein coated TCPS as well as glass have previously 
been employed as infinitely stiff substrates (in the order of MPa) and allow to extrapolate 
the maximal stiffness of PA (~80kPa) (226;227). 
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While on all substrates HAC attachment in chondrogenic medium roughly matched which 
with values previously found under expansion conditions (140), proliferation of re-
differentiating HAC was very low on both soft and infinitely stiff substrates. This allowed 
to bypass proliferation inherent de-differentiation (95), which may have clouded the 
analysis of matrix elasticity as a direct differentiation cue in previous studies (208). 
 
Morphology & Sox9 Expression 
The soft substrates were demonstrated to permit for similar HAC morphology as can be 
achieved by well established culture conditions, which have been described to support a 
round cell morphology (96;101;124;212-215). In fact, HAC cultured on soft PA substrates 
in chondrogenic medium displayed characteristic aspects of chondrocytes in situ 
(228;229), including a round/spherical morphology, cortical actin filament organization 
and the lack of focal adhesions. Moreover, the morphogical observations in the present 
work were in good agreement with a complementary study, which assessed the 
maintenance of porcine and bovine chondrocytes in response to matrix elasticity 
(208;230). 
Contrastingly, Intermediately stiff to infinitely stiff substrates, allowed for cell spreading, 
actin stress fibre formation, and focal adhesion assembly which coincided with reduced 
Sox9 transcription factor expression/nuclear-translocation and type II collagen (mRNA 
and protein) expression. This coincidence suggests for the involvement of Rho GTPases, 
which are well characterized upstream regulators of the actin cytoskeleton (231;232) and 
have been found to influence chondrocyte differentiation and function. More specifically, 
RhoA and its effector ROCK suppress cortical actin organization, lead to stress fibre 
formation, the maturation of focal adhesions and inhibits chondrogenesis through the 
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supression of Sox9 expression (165;233). To date, Sox9 is known to be the only 
transcription factor absolutely necessary for chondrogenesis (234-236) and directly 
regulates the transcription of the collagen II gene (236-238). 
That Sox-9 expression was heterogeneous throughout the cell population may reflect the 
different zonal origins of HAC harvested from whole articular cartilage. This complicates 
the analysis of the fluorescence images and prompts for a quantitative assessment of 
nuclear Sox-9 translocation (normalized to cytoplasmic levels) to more precisely estimate 
its promotor activating levels (in progress). 
 
Chondrodifferentiation 
Matrix elasticity per se has been demonstrated to be sufficient for directing lineage 
specification of MSC (109), but it did not induce re-differentiation of HAC. This suggest, 
that although HAC expanded in presence of specific growth factors assume MSC-like 
traits (100), they might not fully acquire the degree of plasticity of their progenitors. 
Although not additional, substrate elasticity was able to modulate the soluble chondro-
inductive stimulus provided by TGF. This suggests for a cross talk between soluble and 
insoluble signals and implies that depending on the mechanical compliance of their 
environment, cells might respond differently to the same soluble signal. This has first 
been demonstrated for contractile fibroblasts, which only were able to maintain/generate 
TGF induced α smooth muscle actin (αSMA), when cultured on stiff (20kPa) but not on 
soft (8kPa) collagen gels (239).  
 
The strong up-regulation of type II collagen mRNA in HAC on soft substrates is in 
agreement with findings of a previous study using porcine chondrocytes (208). However, 
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the differences in type II collagen mRNA expression between the softest and the stiffest 
substrate were found to be more pronounced as than those reported by Schuh et al. 
(2010). This could be due to the difference in cell type and/or to the aforementioned 
proliferation associated de-differentiation. Another reason could be, that the softest 
substrate (4kPa) used by Schuh et al. (2010) was more than 10-fold stiffer as compared to 
the soft substrates (0.3kPa) employed in the present study. 
 
The reason why type II collagen was mainly found intracellularly but not extracellularly 
is unclear but could possibly be due to blocked release from HAC or low retention on the 
inert PA substrates. Interestingly, the staining was not continuous but localized into small 
granular features which were scattered throughout the entire cytoplasm. Similar, staining 
has been observed in chick chondrocytes and attributed to type II pro-collagen (209). 
Although, the type II collagen expression looks promising, these are primary results, 
which need further confirmation. 
 
Interestingly, the E modulus of the soft substrates matches well with values reported for 
mesenchymal stem cells (240). Since in the developing limb bud, mesenchymal stem cells 
aggregate to form mesenchymal condensations (205) this implies that they might greatly 
determine the mechanical properties thus suggests, that the soft substrates could have 
mimicked the mechanobiological environment present at the onset of chondrogenesis. 
In chondrogenic medium, Type I collagen mRNA expression by HAC was rather high in 
both aggregates and on soft substrates. This could be due to the fact, that 7 days of re-
differentiation is still quite short. Actually, it is known, that in the developing limb, 
Collagen I plays an important role during mesenchymal condensation but is down-
regulated as chondrogenesis progresses (218). 
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Mechanisms of Mechanotransduction 
The precise mechanisms by which substrate elasticity influences cell behaviour are still 
elusive (241). Still, the number of studies which provide mechanistic insight on the topic 
of mechanotransduction is increasing and has let to the proposal of different models. 
An extracellular model describes that if cell generated tension meets resistance from the 
ECM, it allows to free/activate latency associated protein (LAP) bound growth factors 
(i.e. TGF) which are sequestered in their inactive form throughout the ECM (207). 
However, it seems unlikely, that matrix elasticity modulated the effect of TGF by this 
mechanism, since the chondrogenic medium was supplemented with free/active TGF and 
since type I collagen (immobilized on the PA substrates) is not known to possess a TGF 
or a LAP interaction site. 
 
Other models focus on intracellular effects of matrix elasticity. The strain within a cell is 
manifested as protein extension, domain unfolding, and or protein-dissociation that 
relieves stress and/or creates sites for new binding partners, which elicits a chemical 
diffusion based signalling (241). Alternatively, external forces are thought to propagate 
into the cell nucleus through cell surface transmembrane receptors, that couple the ECM 
to cytoskeletal networks, which in turn link to nuclear scaffolds, nucleoli, chromatin and 
DNA. This channelling of forces across discrete load-bearing cytoskeletal filaments might 
promote changes in the shape, folding or kinetics of specific, load-bearing molecules or 
might modify higher-order chromatin organization and thereby alter nuclear protein-self-
assembly, gene transcription, DNA replication or RNA processing. Moreover, this model 
suggests, that tissue elasticity as an insoluble cue could specify genome organization and 
nuclear matrix composition, which could prime cells to react differently to the same 
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soluble signal through differential tethering of genes to load-bearing nuclear scaffolds 
(242). Likely, both the chemical diffusion based, and the direct nuclear 
mechanotransduction work in a complementary/integral fashion. 
 
 
OUTLOOK 
The adhesive ligand employed in this work was restricted to type I collagen, but could be 
extended to other ECM proteins as i.e. type II collagen, which has been shown to support 
the native morphology of chicken epiphysial chondrocytes (129). This suggestion also 
finds support by the fact that myogenic and osteogenic differentiation of human MSC can 
be directed by the interplay of substrate stiffness and type of adhesive ligand presented 
(243). 
Instead of using native proteins like type I collagen, engineered proteins (i.e. modified 
FN-fragments) or truncated proteins (i.e. RGD-containing peptides) could also be used as 
cell-ligands and have previously been demonstrated to modulate the behavior of human 
fibroblasts and HAC respectively (137;140). 
 
Although the two dimensional (2D) PA gels employed in the present work proofed to be a 
valuable tool, future experiments to investigate the effects of substrate elasticity on cell 
behavior should be performed in a three dimensional environment (3D). 3D culture 
systems possess fundamental advantages over 2D models as they allow cells to adopt 
their native morphology, increase cell-cell interactions and facilitate contacts with the 
ECM (244;245). Moreover, a 3D environment would be more representative of i.e. an in 
situ situation and thereby be clinically more relevant. Unfortunately, PA polymerization is 
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not compatible with living cells, and thus does not allow for cell encapsulation. A simple 
approach to bypass this technical obstacle could be culturing cells in aggregates mixed 
with PA micro particles. Together, the 2D and the 3D PA model could allow to 
investigate cell responses to the influence of substrate elasticity & architecture in 
combination with other parameters such as soluble factors and/or the type of immobilized 
cell adhesion ligand. 
A more sophisticated alternative would be i.e. PEG-based hydrogels which allow for cell 
encapsulation under physiological conditions and also can be tuned in their elasticity. 
Furthermore, PEG-based hydrogels can be doped with biological functionalities as i.e. 
matrix metalloproteinase-sensitive motifs and thus allow for enabling and controlling 
their biodedradability (246). This stands in strong contrast to most other synthetic 
materials which cannot be remodeled by cells, are limited in their degradation 
(hydrolysis) and thus may not be compatible with the de novo formation of matrix by 
cells (247). Still, PA-gels can easily be prepared in a biology lab since all the required 
ingredients are commercially available and simple to assemble. PEG-gels are not more 
complicated to assemble, yet, their building blocks cannot be bought off the shelf, but 
first have to be synthesized and characterized. 
Taken together, 2D PA gels and 3D PA microparticles could be further exploited as 
simple but potent model tools in basic biology, while for rather clinically oriented 
investigations more sophisticated materials should be considered, which not only are 
biocompatible but also can be remodeled by cells. 
 
Based on their chondroprogenitor like plasticity (100), expanded/de-differentiated HAC 
may provide a prediction on the behaviour of bone marrow derived mesenchymal stem 
cells, which are receiving increasing interest in association with in situ cartilage repair 
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approaches(152). These repair procedures involve the penetration of the subchondral bone 
plate by small perforations (microfracturing) which allow the recruitment/infiltration of 
mesenchymal stromal cells (MSC) from the bone marrow (204). MSC have the potential 
to undergo chondrogenic differentiation (156), but are thought to require the support of 
inductive/instructive biomaterials to improve microfracturing stimulated in situ cartilage 
regeneration (152;203). In this light, it appears promising to also investigate the effect of 
matrix elasticity on the chondrogenic differentiation of human MSC. 
 
 
 
CONCLUSION 
Substrate elasticity modulated the re-differentiation response of expanded/de-
differentiated HAC to the chondrogenic stimulus TGFβ-3, and thus underscores 
mechanical compliance in combination with appropriate soluble signals to be important 
parameter in designing biomaterials for cartilage repair. 
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Main Conclusion 
 
 
 
By modifying specific substrate characteristics, CPC behaviour could be modulated under 
conditions which were either permissive for proliferation or differentiation. In chapter I 
for example, substrate composition & architecture were found to modulate the 
chondrogenic differentiation of MSC. That the di block copolymer model substrate 
(Polyactive®) with a more hydrophobic composition better supported MSC 
chondrogenesis, is likely associated with differential protein adsorption (from serum 
containing medium). However such proteinaceous interfaces are rather complex with 
regard to protein composition and conformation thereon. As this conceals the specific 
cues responsible for mediating the observed effects, it consequently prompted for 
reducing substrate interface complexity in subsequent investigations (chapter II & III). 
A 3DF architecture with more highly interconnected pores and a pore size that allowed 
for the formation of larger MSC aggregates than the CM scaffolds was found to 
considerably better support MSC chondrogenesis. Taken together, the findings in chapter 
I underscore the importance to control substrate composition & architecture and point to 
their potential to modulate CPC cartilaginous matrix formation from fibrous towards 
more hyaline like. 
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Chapter II proofed, that restricting cell/substrate interaction to a specific ligand type 
(RGD-containing peptide) modulates de-differentiation of proliferating HAC and their 
subsequent capacity to form cartilaginous matrix. This demonstrated the advantage of 
small ECM fragments in combination with protein resistant materials to control 
cell/surface interaction. An important finding was the better maintenance of the HAC 
chondrocytic phenotype during expansion. It suggests, that an RGD-restricted substrate 
has the potential to improve the outcome of matrix assisted in situ cartilage repair, which 
initially requires recruited/infiltrated CPC to proliferate, while keeping/inducing their 
capacity to form cartilaginous matrix. 
 
In chapter III, substrate elasticity allowed to modulate the chondrogenic commitment of 
HAC. The finding, that a soft substrate (0.3kPa) better supported the chondrogenic 
phenotype of HAC than i.e. a stiffer substrate (75kPa) suggests this parameter to be 
promising for modulating the outcome of matrix assisted cartilage repair. 
 
All chapters clearly demonstrated the potential of substrate properties to modulate CPC 
behaviour. Yet, although differentially supporting CPC chondrogenesis, none of the 
substrates was per se chondro-inductive (see chapter I and III) but required for additional, 
exogenic stimuli as for e.g. TGF. Thus, substrate modifications hold considerable 
potential for improving matrix assisted cartilage repair but likely have to be combined 
with additional soluble stimuli to exploit their full potential. 
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Main Outlook 
 
 
For reasons of feasibility, the sequences following micro fracturing stimulated cartilage 
repair have been grouped into two main phases consisting of i ) proliferation and ii) 
differentiation. From these phases in vitro conditions were inferred for testing the 
response of condroprogenitor cells (CPC) to specifically modified substrate interfaces. 
However, aiming at in situ repair, these two phases would have to be linked. Thus, the 
supportive properties found in this thesis would have to be provided by one and the same 
material. This could be accomplished by a dynamic, clock-like material that adapts to the 
specific needs during the two different phases. As an example, such a hypothetic material 
could be an RGD-restricted, relatively stiff substrate (≥20kPA). After a duration long 
enough to allow for proliferation, the material would need to soften (~1kPa) for 
supporting chondrogenic differentiation of the augmented CPC pool. The architecture of 
the envisioned ideal material initially should allow for efficient CPC infiltration and 
distribution but also should permit the formation of cellular aggregation during 
chondrogenic differentiation. These requirements could possibly be met by a single 
architecture like the 3DF. 
As mentioned above, such a supportive material should be combined with appropriate 
soluble factors to stimulate either proliferation or induce differentiation. The release of 
these factors should be in concert with the corresponding phase of cartilage repair and 
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could be preceded by a burst of suitable cytokines to enhance CPC recruitment/ 
infiltration. 
Combining supportive substrate properties with inductive soluble stimuli, it should 
ultimately be possible to move from biomaterials which support cartilaginous repair to 
active medical devices which mediate cartilage repair. 
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